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1. INTRODUCTION 
The Siddha Medicine is one of the oldest medical systems and is the unique nature 
of this system is continuous service to humanity for more than 5000 yrs in combating 
disease and maintaining the physical, mental and health. 
 The word Siddha comes from the word siddhi which means an object to be 
attained perfection or heavenly bliss. 
 The term Siddha means “knowledge of life” (or) perfection, everlasting, even 
sure. 
 Siddha is based on the premise that the universe is made up of five elements:  
Earth, Water, Fire, Air, and Ether. It is well mentioned in, 
 
ÂUkªÂu« - 1937 
“ cuko nkÂå ÍªÂæy¥gh« 
éuéa j‹Kiy nkè¡ÑH§» 
fUKiy Ûäir if¡Ñê‰ fhyh« 
éuéa fªju nkš btëahnk” . 
e« cliy gŠrój¤Jl‹ x¥ÃLt®. cliy¤ jh§F« cWÂahd ghj« ãy« 
MF«. ghj¤ÂèUªJ bfh¥óœtiu ÚuhF«. bfh¥òèUªJ kh®ò tiu ÔahF«. 
kh®ÃèUªJ njhŸtiu fh‰whF«. fG¤J¡F nkny thdbtëahF«. Ï›thwhf 
ekJ cl«Ã‹f© I«bgUk¥ójãiy ã‰»‹wd. 
These Five elements are represented in humans by Three “Thodams” namely – 
Vadham, Pitham, Kabam. When any of the Thodams accumulate in the body beyond the 
desirable limit, the body loses its balance. Every individual has a distinct balance; health 
& well being depend on getting a eight balance and causes the illness. 
 As per Siddha literature, human physiology & pathology are based on three 
humors, pancha boodhas, ninety six thathuvams & seven Udal Thathukal. 
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 Balavagadam (or) Kuzhanthai Maruthuvam is one of the Siddha literature which 
deals with the diseases of children. Infectious disease and nutritional deficiency are twin 
problem among the health problem of children affectively their growth & development. 
In paediatric “Kabasuram”is one of the commonest infective disease. 
 In our Siddha literature, Kabasuram is described as fever, cough with (or) out 
expectoration, Arthralgia, headache and constipation. Most of the Clinical features of 
Kabasuram are more or less similar to that of acute bronchitis. 
 Acute bronchitis is infectious disease of the respiratory tract. Acute bronchitis 
affects the children in their active period of life and it is prevalent throughout the world 
and is one of the top five reasons for childhood physician insist in countries that track 
such date. 
 Siddha literature having more number of efficacious medicine for Kabasuram, 
even though there are more number of research findings have been published for the 
above ailment but not yet have scientifically validated days available for the Kabasuram. 
 Hence author have chosen the authenticated sasthric Siddha poly herbal 
formulation namely Silaethuma Sura Kudineer for the management of Kabasuram, 
which is mentioned in literature Agasthiyar Vaithiya Kaviyam 1500. 
 
 
 
 
 
 
 
  
 - 3 - 
2. AIM & OBJECTIVES 
Aim: 
To evaluate the efficacy of Silaethuma Sura Kudineer for the management of 
Kabasuram (Acute Bronchitis)  
 
Objectives: 
· To collect & review the ideas mentioned in the ancient Siddha literature 
about the disease. 
· To explore definitions, etiology, Clinical features, diagnosis, investigations 
& treatment of Kabasuram as laid down from various Siddha literature. 
· To study the disease Kabasuram on the basis of three thodam, 
Envagaithervugal, Neerkuri, Neikuri, Udal Thathukkal, Paruva kaalangal, 
Age, Sex & economic status. 
· To make the correlative study of Siddha & modern aspect of this disease. 
· To use the modern parameters in the investigation of the disease that 
enhances to obseque the progress of the patient. 
· To conduct a clinical trial to find out the efficacy of Silathuma Sura 
kudineer. 
· To have a detailed analysis of the clinical efficacy of the drug through the 
pharmacological biochemical analysis.   
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3.a.SIDDHA ASPECT 
Ru« 
 “é©â‰ njt®¡ bfšyh« 
  és§Fkhš Kjšt‹nghy 
 k©âdh® nehŒ¡F K‹dhŒ 
  tUŠRu Kjny ba‹D« 
 g©âa ãjhdª j‹id¥ 
  ghlnt gts nkå¡ 
 f©Qj‰ flÎŸ bg‰w 
  fzgÂ fh¥ò¤ jhnd”. 
 
bghUŸ 
 njt®fë‹ jiyt® ÂUkhny ngh‹W nehŒfS¡F¡bfšyh« Ru nehna 
Kjyhtjh«. 
        -      njiua®  thfl« 
I. nehŒ Ïašò 
   “ brhšynt Ru¤ÂYl ÂwiknfshŒ 
    rl¤ÂYŸs gâ¡bfšyh äuhrhyhF« 
   všybt ekD¡F bkh¡F bkh¡F 
    bkênyhF Ãuyhg nfhgkhF«. 
   jŸsny j¡fål ntŸéid¤jh‹ 
    rh«gÁt‹ nfhg¤jh yê¤jnghJ 
   bešyny be‰¿¡f© Ryhiy¤j‹åš 
    neuhf¥ òw¥g£L ne®ªjjhnk.” 
       - ô»it¤Âa Áªjhkâ 
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 eh¡F, _¡F M»ad btë¤J¡ fhz¥gL«. kh®ò nehF«, ÏUkš Ïis¥ò 
M»ad njh‹W«, _¢R él Áuk«, é¡fš jhf« M»ad njh‹W« bjh©il 
nehF«, nkš _¢R th§F«, ÂdbyL¡F«. 
II. ntWbga® (Synonyms) 
   “ bt«ik bt¥ò btW¡F§ fhŒ¢rš 
    J«kh¡ fh§if NL fHydš 
   R«ik¥ Ãw¥Ãš Ïw¥Ãšbjh l®nehŒ 
    g«knehŒ fhªjš  gybga® Runk. 
        - Á¤j kU¤Jt« (bghJ) 
bt«ik, bt¥ò, btW¡F« fhŒ¢rš, J«kh¡fh§if, NL, jHydš, R«ik, 
Ãw¥ÃY« Ïw¥ÃY« bjhlU« nehŒ. g«kš nehŒ, fhªjš vd gy bga®fŸ c©L. 
 
III. nehŒ tU« tê (Etiology) 
1. According to Siddhar Theraiyar 
 First kabam will be increased in the stomach and then due to its action body 
temperature will be increased & it results in fever. 
Flš j‹åš ÓjkyhJ RuK« thuhJ njiua® 
2. According to pothu Maruthuvam 
· kªj« 
· ky¡f£L 
· K¡F‰w§fŸ äFÂ¥gL¤j¡Toa czÎfis c©zš 
· äFªj Fë®¢Á 
· äF gå 
· äFªj fh‰W 
· él¡ fh‰W 
· mÂfkhd Úuhlš 
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· él« fyªj czÎ 
· fL« btæèš Âçjš 
· kiHæš eidjš 
· njf¤Âš él òG¡fŸ br‹W Jis¤jš 
 M»a Ï¤ÂahÂ mf k‰W« òw¡ fhuz§fshš të, mHš, Ia« v‹D« 
K¡F‰w§fS« nflilªJ äFªJ gy cW¥òfS¡F nehia éisé¡f¡ 
Toajhd Ru¤ij c©lh¡F«. 
3.According Roga Nirnaya Saram 
· mÂ eil 
· mWRit t°J ngj« 
Ïitfshš thj, Ã¤j Ány¤Jk§fŸ mÂfç¤J Ój¡f£L °jd¤ij¥ 
g‰¿ Éuâ¡fhj m‹dur¤ij¥ mDrç¤J, eu«ò nuhk¤ Jthu§fis mil¤J 
ehÃ °jhd¤Âš nr®ªJ #luh¡»åia nkèš vG«Ã mjDl‹ fyªJ r®th§f« 
éah¥Ã¤jyhš Ru« Ãw¡»wJ. 
IV.K¡F¿ Fz§fŸ (Premonitory Symptoms) 
 Before the onset of fever, some of the premonitory symptoms will be seen. 
· gÁæ‹ik 
· clš tè 
· eh tw£Á 
· czÎ btW¥ò 
· eë® 
· thŒ if¤jš 
· Ãj‰wš 
· TRjš 
· »W»W¥ò 
· ka¡f« 
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· njf§F¤jš 
· Ïuéš ö¡fä‹ik 
· eh Rita¿ahik 
· czÎ brçaik 
According to Roga Nirnaya Saram 
· Ru« 
· ky¡f£L 
· njf tè 
· gÁæ‹ik 
· jhf« 
· f© vçÎ 
· jiy ghu« 
V.CLASSIFICATION OF FEVER: 
According to various siddha literature  
 
   Book Name                                                  Type of Fiver 
 
1. Balavagadam – Dr.Pon.Kurasironmani  20 
2. Pillaippini Maruthuvam – Dr.A. Sundaresan  32 
3. Siddha Maruthuvam Podhu –  
 Dr. K.N. Kuppusamy Reddiar  64 
4. Seevaratchamirtham – Arumuga Pillai  312 
5. T.V. Sambasiva Pillai Agarathy  64 
6. Yugi Vaithya Sinthamani  7 
7. Theraiyar Vagadam  40 
8. Agathiyar Vaithiya Rathina Surukkam  85 (64) 
9. The hand book of Indian medicine by 
 T.G. Ramamoorthi  85  
 
 - 9 - 
fgRu« 
According to Balavagadam,there are 20 types of fever,one among is kabasuram 
I. ntWbga® 
 Ány¤Jk Ru«, Ój Ru«, Ia Ru« 
 Ia¤Â‹ Ïa‰if ãiyfŸ, mj‹ äF Fz« ngh‹wt‰iw x¥ò neh¡F« 
bghU£L Ñœ¡f©lthW bjhF¡f¥gL»‹wJ. 
 Ia« - cæ® jhJ 
II. j‹ik 
 j‹ik, beŒ¥ò 
 kªj«, tGtG¥ò 
 bk‹ik, Â©ik. 
III. thGäl« 
 rkhdthÍ, RGKid 
 M¡»id, éªJ 
 eh¡F, c©zh¡F 
 bfhG¥ò, k¢ir, FUÂ, kh®ò 
 eu«ò, vY«ò, _is, bgU§Flš 
IV. Ïa‰if¥ g©ò 
 ãiy¤jš 
 beŒ¥ò 
 Ñœfë‹ mik¥Ã‹ f£LfŸ 
bghiwÍilik (gÁ, Ú®nt£if,  fy¡f« ngh‹wt‰iw bghW¤J¡ 
bfhŸSjš) 
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V. IaäFFz« 
· m¡»å kªj¥glš 
· thŒÚ® Cwš 
· C¡f« Fiwjš 
· clš fdkhf njh‹WtJl‹ Fë®¢ÁiaÍ« miljš. 
· clš K‰W« cŸs f£LfŸ jsuš 
· Ïiu¥ò, c¥Ãr«, ÏUkš äFö¡f« c©lhjš 
VI.Kabasuram in various Siddha Literature 
1. According to Balavagadam 
IaRu« 
 kh§»rª j‹åš thj kJÃ¤j« jhDªnjhèš 
 ö§»L bkY«ÃiyaŠ Rfkw¤ njh‹¿¥ Ã‹d® 
 rh§»a khf ã‹W rßu¤Âš nehÍ« g©Q« 
 M§»ij¢ brhšy bth©zh jÔjkh« njhfªjhnd 
FHªijfS¡F c©lhF« Ru« Iakh»š vY«Ãš rh®ªJ cliy btJ¥Ã 
tU¤J«. 
2. According to Pillaippini Maruthuvam 
IaRu« 
 “ brh‹dh Ány‰g RukJ jh‹ 
  njh‹W« FëU« Ã‹RukhŒ 
 k‹dh çUK fh¢rYkhŒ 
  kyK« Ão¤J tæ¦ ¦WhJ« 
 F‹dh®    é£L é£nlnd 
  Fë®ªJ fhšif mi¤J tU« 
 Ï‹dh çªj¡Fz« f©lhš 
  ÏJngh« ehS« gÂndnG”  
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In Kabasuram before the onset of fever, rigor starts first & then followed by fever, 
cough, abdominal distentrion due to constipation, pain present in upper & lower limb & 
also tiredness, sweetness in mouth, pallor of motion & urine, increase of sleep, vomiting, 
salivation & fever gradually reduced within 17 days. 
 
3. According to theriyar Vagadam 
“ gUfnt RuªjhD« gyfh Y©lh« 
ghukh Íl«bg§F« tèÍ©lhF« 
mUfnt ao¡fo¡F éa®itahF« 
m‹dªjh‹ bfh©Llnd thªÂ Í©lh« 
cUfnt yæbešyh Kis¢ryhF« 
c¥ÃrK nkš_¢R äUkY©lh« 
fUfnt ehtu©L Ú®jh»¡F« 
fdkhd RuÁny£g§ fhz¢ brhšny”. 
Remittant fever, body pain, vomiting, perspiration, abdominal pain, abdominal 
distention, cough, dryness of tongue, thirst are symptoms in kabasuram. 
4.According to Theriyar Vagadam 
“ é¡f byL¡fš bkŒnah§fš 
nkå btJ«gš bkŒÂid 
f¡F§ FUnyh Î©bl‹d¢ 
fhny Å§F« Kf« btS¤jš 
 ä¡f m¡»å kªÂ¡F« 
  äfnt Íw¡fª jh‹ tUjš 
j¡f ÏUkš thŒ ÚuhŠ 
  rªã ndhäš éy¡fznk”. 
 é¡fš njh‹wš, clš gU¤jš, clèš bt¥g« fhzš, ÂdÎ©lhjš, fhš 
Å§fš, Kf« btS¤jš, brç¥ò¤j‹ik F‹Wjš, ä¡f cw¡f§fhzš, ÏUkY«, 
thŒÚ® CwY« njh‹Wjš. 
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5.According to Agathiyar Aayul Vedham 
 “ jiyd¤Jlš btJ«Ãj‹ bré_¡fil¡F 
  äy»aÎju K‰¿éiuªJ bkŒRS¡F¡ F¤J 
 éy»na ardŠbršyh btJ«Ãna Ány®¥gd¤Âš 
  ãyèaRu§fŸ f©L ã¢rak¿ªJ brŒna”. 
jiy fd¤Jl‹ clY« btJ«Ã bré, _¡F M»ait mil¤J¡ 
bfhŸS«, tæW K‰¿ éiu¤J éL«. cl«Ãš RS¡bfL¤J F¤J©lhF«, 
czéš éU¥g« ÏU¡fhJ. 
 
6.According to Pararasasekaram Balaroga Nidhanam 
 “ br‹åäf¡ fd¤Âo¤J¢ Ó¿Kf K§fd¤J 
  ä‹Dkdš ngh‰RuK bk‹nkY nkKL» 
 k‹DÁu¤ ölÂf tèæo¥ò nkahF« 
  m‹deil ä‹ndæ j¿iynr‰ gdRunk”. 
Heaviness of head, anger, puffiness of face, high grade fever, severe headache, are 
the symptoms of Kabasuram. 
 
7.According to Roga Nernaya Saram 
f©, Kf«, _¤Âu«, ky« btS¥ò fhQ«. ÏUkš, nfhiH, beŠÁš tè 
fhQ«. fghÂ¡f¤Âdhš c©lhd Ru¤Âš if, fhš fd¤jš, ÁuÁš  Ú® bfh©L 
tè, clš Ïis¤jš, é£L é£L Ru« mo¤jš, beŠRtè, eL¡f«, jiyæš 
éa®it, mnuhÁf«, mÂf ö¡f«, tæ‰¿š vç¢rš, thæš Ïå¥ò, ÏUkYl‹ 
nfhiH, thªÂ, nrh®Î M»a F¿ Fz§fŸ fhz¥gL«. 
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VII. F‰w Kjèa ntWghLfŸ (Three humours derangement) 
“ tF¤j Kiw¥ghL kªj¤jhš thÍth« 
äFªjdš thÍthš éiyªÂL« nehnaah« 
gF¤Âit Ïu©lhš gh®m¢ RuKJ« 
Kf¤jiy _‹wš K¤njhõ§fhDnk”. 
 clèš kªj« V‰g£lhš thÍ c©lhF«. thÍÎ« kªjK« TLyjhš RuK«, 
Ru« thÍ kªj« _‹W« TLjyhš clèš thj, Ã¤j, fg njhõ§fŸ éf‰f¥g£L 
nehŒfŸ V‰gL»‹wd. 
       - gÂbd‹ Á¤j® eho Ehš 
VIII. eho eil 
 “thjfg eho, Iaeho, fgÃ¤j eho 
  Ia Ru¤Âid bjhlU« nehŒ”. 
IX. Ûshj IaRu« 
 “ IaRu¤Â‹ Fz§nfsh afL bghUä¡f©btS¡F« 
  ifÍ« fhYŠ nrh®ªJéG« f©f SŸns jh‹ÅG« 
 bjhŒaš RuK« élhjJÎ« brhšYªnjhl khdh‰nghš 
  bkŒÍ eh¡F nkyu©L é¡fbyL¤J Ûshnj 
 bkŒæš yªj itaRu« é£Lé£ljh‹ btJ«Ã¡ 
  ifÍ§ fhYnk btJ«Ã¡ f‹d§fhÍ beŠÁo¡F« 
 cŒÍ KHiy thªÂÍ©nlh nkhonaho¡ f£L« 
  ija« ÃiH¥g jçJ©lh aÂf khFŠ Ruªjhnd” 
         - ghythfl« 
X. Ôuh IaRu« Ïašò 
 “ bjhiy¡FŠ nr¤Jk¡ Fz§nfë® 
  bjh©il j‹id¥ òifªÂUK« 
 ky¤ij btS¡F« thlhkš 
  tUªÂ a§f äfbtJ¥ò« 
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 jy¤J¡ »ilÍ§ bfhŸshJ 
  jiyia¤ bjç¡F« j©Ùuh« 
 ky¤ij äfnt ngh¡» it¡F« 
  ngÓ® Ány¤Jk Rubk‹nw 
 bjh©ilæš òif¢rYl‹ ÏUkš 
  ky¤ij btS¤jš brŒÍ«” 
 m§fbkšyh« bt¥gkiljš, jiyæš bt£LtJ ngh‹w tè fhzš, clš 
mo¡fo éa®¤jš, gL¡ifæš bghUªjhik, Ïu©L fhšfŸ, iffŸ, f©fŸ, eh 
Ïit btS¤ÂL«. ghiy éU«Ã ä¡f bjhªjuÎfŸ brŒÍ«. 
 
XI.nehŒ fâ¥ò 
 Á¤j kU¤Ât¤Âš nehŒ fâ¥Ãš Ã‹tU« fhuâfŸ K¡»a g§F t»¡»‹wd. 
nehahëia¢ rh®ªjJ 
1. cæ® jhJ¡fŸ (K¡F‰w«) 
2. clš jhJ¡fŸ (cl‰ f£LfŸ) 
3. v©tif¤ nj®Î 
nehahëia rhuhjJ 
4. msit 
5. bghGJ 
               bgU«bghGJ ; fh®, fÂ®, K‹gå, Ã‹gå, Ïsntåš, KJntåš. 
               ÁWbghGJ ; itfiw, éoaš, V‰ghL, e©gfš, khiy, ahk«. 
        6. Itif ãy§fŸ 
- F¿ŠÁ, Kšiy, kUj«, beŒjš, ghiy. 
nk‰T¿a fhuâfë‹ khWghLfis x‹Wl‹ x‹W x¥Ã£L nehŒ 
fâ¡f¥gL»wJ. 
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cæ® jhJ¡fŸ 
thj« 
t.v© tiffŸ gâfŸ 
1 Ãuhz© 
· _¢R th§fš, éLjš brŒÍ« 
· òÁ¡F« czÎfis brç¡f¥ g©Q« 
2 
mghd‹ 
(Ñœneh¡Ffhš) 
· kyry¤ij¤ jŸS« 
· Mrdthia RU¡F« 
· m‹drhu¤ij¢ nru nt©oa Ïl§fëš 
nr®¥Ã¡F« 
3 éahd‹ (guÎ¡fhš) 
· cW¥òfis Ú£l kl¡f¢ brŒjš 
· gçr§fisa¿jš 
· c©Q« czé‹ rhu¤ij mšèl§fëš 
ãu¥Ã¤J cliy¡ fh¡F« 
4 
cjhd‹  
(nkš neh¡F¡fhš) 
· czé‹ rhu¤ij m§f§nf ãW¤J«, 
btë¥gL¤ÂÍ«, fy¡»Í« tUjš brŒÍ« 
5 Rkhd‹   (eL¡fhš) 
· thÍ¡fis äŠr bth£lhkš kl¡»¢ 
rç¥gL¤Â¢ nru¥ g©Q« 
· mWRitfisÍ«, j©Ù®, m‹d« 
M»at‰iwÍ« rk¥gL¤Â clèbyšyh« 
nrU«go brŒÍ« 
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6 ehf‹ 
· m¿it vG¥ò« ešy g©fis¥ ghLé¡F« 
· f©fis¤ Âw¡F« go¢ brŒÍ«. f©fis 
Ïik¡F«go brŒÍ«. kæ®fis¢ Áè®¡f¥ 
g©Q« 
7 T®k« 
· Ïikia¡ bfh£Lé¡F«. bfh£lhé 
él¥g©Q«. f©fis¤ Âw¡fÎ« _lÎ« 
g©Q«. cyf¥ bghUŸfŸ aht‰iwÍ« 
f©fS¡F  fh©Ã¡F« f©fëå‹W« 
Úiu éH¥ g©Q« 
8 »Ufu‹ 
· ehé‰fÁitÍ«, ehÁæ‰ fÁitÍ« 
c©lh¡F«. gÁia c©L g©Q«. x‹iw 
ãid¤ÂU¡f¢ brŒÍ«. nghj‰bwhêiy¢ 
brŒÍ«. J«kiyÍ« ÏUkiyÍ« c©lh¡F« 
9 njtj¤j‹ 
· r©il bfhŸsš, j®¡f« ngrš, ä¡f nfhg« 
· kpF Nrhk;gy; 
10 jdŠra‹ 
· jiy bto¤J ÏJ _¡»èUªJ jo¤J cl«ò 
KGikÍ« Å§f¥ g©Q«. fhÂš flš 
nghèiuÍ« ÏwªJéo‹ fh‰bwšyh« 
btë¥g£l Ã‹d® _‹whtJ ehëš jiy 
bto¤j Ã‹ jh‹ nghF« 
In patients with kabasuram following vadham are commonly affected. 
Pranam – Cough, Expectoretion, Breathlesness 
Abanan – Constipetion 
Uthanan – Vomiting, Cough 
Kirukaran – Running Nose, Cough 
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           Ã¤j« 
           Pitham – It helps for all the transformation 
t.v© tiffŸ gâfŸ 
1 ghrf« (md‰ Ã¤j«) 
· c©l czÎ¥ bghUŸfis¢ brç¡F«go 
brŒÍ« 
2 
ÏuŠrf«      
 (ÏuŠrf Ã¤j«) 
· brªÚiu äFÂ¥ gL¤J« g©òilaJ. 
Ïiu¡ FlèèUªJ  bfh©L 
czéèUªJ ÃçªJ©lhd rhW¡F¢ 
brªãw¤ij¤ jU»wJ 
3 rhjf¥ Ã¤j« 
· ÏJ ãiwnt‰W« g©òilaJ. kd«, ò¤Â, 
g‰W Ït‰iw¡ bfh©L éU¥gkhd 
bjhêiy¢ brŒJ Ko¡F« 
4 Mnyhrf Ã¤j« 
· ÏJ f©fS¡F¥ bghUŸfis¤ 
bjçé¡F« g©òilaJ 
5 Ãurhf Ã¤j« 
· njhY¡F xëia¡ bfhL¤J mij xëu¢ 
brŒÍ« 
 
In patients with Kabasuram, the following pitham, commonly affected. 
            Analagam – Loss of appetite 
            Ranjagam – Paleness of  the conjunctiva and tongue. 
           Sathagam- Difficulty to do the routine works properly. 
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fg« 
Stabilizes, Maintains and lubricates all movements. 
t.v© tiffŸ gâfŸ 
1 mty«gf« · eh‹F Ia§f£F g‰W¡nfhlhæU¤jš 
2 »nyjf« 
· czÎ¥ bghUis Ú® Kjèaitfis 
<u¥gL¤Â bk¤bjd¢ brŒÍ« bjhêiy¥ 
òçÍ« 
3 nghjf« 
· ehéå‹W c©Q»w Ritfis 
m¿é¡F« bjhêiy¥ òçÍ« 
4 j‰gf« 
· jiyæå‹W f©fS¡F Fë®¢Áia¤ 
jU« 
5 rªÂf« 
· ÏJ ó£Lfëš ã‹W všyh¡ ÑšfisÍ« 
x‹nwhblh‹W bghU¤Â¤ jsu¢ brŒJ 
bfh©oU¡F« 
 
In patients with Kabasuram, the following kabam, commonly affected. 
Avalambagam – Cough with expectoration 
Kilaethagam –poor appetite 
Santhigam-arthralgia  
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cl‰jhJ¡fŸ 
t.v© tiffŸ gâfŸ 
1 rhu« · cliyÍ«, kkijÍ« C¡fKw¢ brŒtJ 
2 brªÚ® 
· m¿Î, t‹ik, xë, brU¡F, xè Ïitfis 
ãiy¡f¢ brŒtJ 
3 C‹ 
· clè‹ cUt¤ij mj‹ bjhê‰»z§f 
mik¤jY«, v‹ig ts®¤jYkh« 
4 bfhG¥ò 
· x›nth® cW¥ò« j¤j« braiy Ïa‰W« 
bghGJ fodä‹¿ Ïa§f mt‰¿‰F 
beŒ¥ò¥gir C£o cjé òçtJ  
5 vY«ò 
· cliy xG§Fgl ãW¤Â it¤jš, 
bk‹ikahd cW¥òfis¥ ghJfh¤jš, clš 
miré‰F mo¥gilahæU¤jš M»a 
brašfis¢ brŒtjh« 
6 _is 
· v‹ò¡FŸ ãiwªJ mitfS¡F t‹ikÍ«, 
bk‹ikÍ« jUtJ 
7 bt©Ù® 
· j‹idbah¤j cUt¥ bgU¡»‰F Ïlkh»a 
fU¤ njh‰w¤Â‰F KjyhŒ ã‰gJ 
 
Among the udal thathukkal, Saram get affected in patients with Kabasuram. In some 
patients senner is also affected  
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3.v©tif¤nj®Î 
1. ehb 
vz;tifj; Njh;Tfspy; gpujhdkhdJ; ehb. gpzpapid ehbahywpe;J 
kUe;J}l;LjNy rpwe;jJ vd;W rpj;j kUj;Jtk; $Wfpd;wJ. Mdhy; Foe;ijfspy; 
ehbeil rhpahf Njhd;whJ vd;gij fPo;fz;l ghlyhy; mwpayhk;. 
 ’nfhz;blNt faNuhfp fhrNuhfp 
  Fwpg;ghf rpw;wpd;gk; nra;j Ngh;fs; 
 mz;blNt jhpj;jpuh;fs; tpUj;jh; ghyh; 
  nfhz;blNt ,th;fspd; cWg;gpd; jhJ 
 $wNt KbahJ vth;f;Ff; fpl;Lk;.” 
Neha;ehly; Neha; Kjy;ehly; jpul;L  
eho eil 
 “thjfg eho, Iaeho, fgÃ¤j eho 
  Ia Ru¤Âid bjhlU« nehŒ”. 
2. ];ghprk;: 
Nehahspapid njhl;L ghh;j;jypd; %yk; czug;gLk; FwpFzq;fs; MFk.; 
fPo;f;fhZk; FwpFzq;fs; mt;thW czug;gl;lJ. 
 - Ruk; 
3. eh 
 Nehahshpd; ehf;fpid ghh;j;J czug;gLk; FwpFzq;fshtd. 
nre;ePh;j;jhJ Fiwe;J fhZjiy> eh ntspwpl;L ,Uj;jyhy; mwpayhk;. 
In kabasuram, some patient has coated and pale tongue. 
4. epwk;: 
 clw;fl;Lfs; td;ik Fiwe;Js;sij mwpa epwg;ghpNrhjid gad;gLk;. 
   In kabasuram no abnormalities found in skin. 
5. nkhop: 
     No abnormalities found in kabasuram. 
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6. tpop: 
 tpopr;Nrhjidapy;>  fPo;f;fhZk; FwpFzk; czug;gl;lJ. 
                       Some patient has pallor in kabasuram. 
7. kyk;: 
  Foe;ijfspy;> tpdhjypd; %yk fPo;fz;l FwpFzq;fs; mwpayhk;. 
· kyr;rpf;fy; 
8. %j;jpuk;: 
 ePh;f;Fwp: 
 ‘te;j ePh; fhpnail kzk; Eiu vQ;rnyd; 
  iwe;jpaYsit aiwFJ KiwNa” 
     - Neha; ehly; Kjy; ghfk; 
ePhpy; epwk;> kzk;> Eiu> vil> vQ;ry;> Mfpatw;iw Nehf;f Ntz;Lk;. 
nea;f;Fwp: 
Foe;ijfspd; ehbeil rhpahf fzpg;gjpy; rpukk; cs;sjhy;> nea;f;Fwp 
ghpNrhjid %yk; Nehahsh; vf;Fw;wj;jhy; ghjpf;fg;gl;Ls;shh; vd;gjid 
fzpf;fyhk;. 
  rpWePiu Nrhjid tl;bypy; Cw;wp xsp kpFe;j ,lj;jpy; ePhpd; 
miyapy;yhj NghJ ey;nyz;nzaj;;Jsp tp;l;L ghh;f;fg;gl;lJ. 
rpyhpy; Mop Nghy; (Nkhjpuk;) gutpAk;> rpyhpy; Kj;JNghy; epd;Wk; 
fhzg;gl;lJ. 
 ‘muntd ePz;bd; thjk; 
  MopNghw; gutpd; gpj;;jk; 
 Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
- Neha; ehly; Kjy; ghfk; 
 
4. msit 
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“ msit fh©lš fUjš ciu  
 mght« bghUŸ x¥gbw‹gh® 
msit nkY« xêò‹ik 
 iaÂf¤ njhoaš bgd eh‹ 
fsit fh©g® mitæ‰¿‹ 
 nkY« miwt® mitbašyh« 
msit fh©g® fUjštiu 
 v‹¿« _‹¿yl§»Lnk” 
      - ÁtÁ¤ msit v©.6 
 
fh©lš – Observation 
fUjš  – Inference 
ciu  – Authority, Literature 
mght« – Perception 
mU¤jh¥g¤Â– Presumption 
cgkhd« – Comparision 
xêò  – Inference by Elimination 
c©ik – Probability  
#Ôf«  – Tradition  
Ïašò  – Natural Inference 
Alavai is divided into 10 types they are, 
The above mentioned ten alavaigal are included in 3 alavaigal they are, 
a. Kaandal Through kaandal the physical care directly see the patient  all the 
complaints and at length concludes a diagnosis. 
b. Karuthal (Through siddha investigation)Through envagai thervu and neerkuri as 
well as neikuri, we can diagnose a disease by karuthal. 
c. Urai literature (Evidence of siddha) Comparative study of the signs and symptoms 
of the patient with the reference books and come to a diagnosis. 
5. Seasons 
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 The whole year is constituted by six seasons. They are known as 
        gUt fhy§fŸ 
· fh® fhy« - Mtâ, òu£lhÁ 
· fÂ® fhy« - I¥gÁ, fh®¤Âif 
· K‹gå fhy« - kh®fê, ij 
· Ã‹gå fhy« - khÁ, g§Få 
· Ïsntåš fhy« - Á¤Âiu, itfhÁ 
· KJntåš fhy« - Må, Mo 
 In every season  changes will occur in the land,water,plants, animals and human 
beings, which will modity the physiology and make them susceptible to certain specific 
diseases which are common in that season. 
 j‹åiy ts®¢Á 
nt‰Wãiy 
ts®¢Á 
j‹åiya¿jš 
thj« KJntåš fhy« fh® fhy« TÂ®, fh® 
Ã¤j« fh® fhy« TÂ® fhy« K‹gå fhy« 
fg« Ã‹gå fhy« Ïsntåš fhy« KJntåš fhy« 
 The incidence of kabasuram is observed in kaarkalam, koothirkalam 
6. Five types of lands: 
It is divided into five types 
  Kurinji  - Mountain regions and surroundings 
  Mullai  - Forest regions and surroundings 
  Marutham - Cultivating regions and surrounding 
  Neithal - Sea coastal regions. 
  Paalai  - Desert land only 
 
 Most of the suffers of kabasuram belongs to neithal and kurinji. 
 
7. Udal vanmai - Body immunity: 
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 The udal vanmai is classified into three types. they are: 
  1. Iyarkai Vanmai 
  2. Seyarkai Vanmai 
  3. Kaala Vanmai 
 
Iyarkai Vanmai: 
 Natural immunity of the body it self by birth 
Seyarkai Vanmai 
 Improving the health by intake of nutritious food materials, activities and 
medicines. 
Kaala Vanmai 
 Development of immunity according to use and the environment when udal 
vanmai is affected there may be a possibility of kabasuram. 
8.kUj;Jtk; 
· Ntw;Wepiy tsh;r;rpaile;j gpj;jj;jpid jd;dpiyg;gLj;j Ntz;Lk; 
· jd;dpiy tsh;r;rpaile;j Iaj;jpid rkg;gLj;j Ntz;Lk; 
· gpj;jFw;wj;jhy; ghjpg;gile;Js;s thjj;jpidAk; rhpg;gLj;j Ntz;Lk;. 
· td;ik ,oe;j clw;fl;Lfis td;ik milar;nra;Ak; tifapy; 
kUe;jspf;f Ntz;Lk;. 
Keeping in mind the need for bringing out an effective therapy for Kabasuram 
from Siddha system of Medicine, the author has undergone this dissertation work with 
Silethuma sura kudineer. 
The dosage of medicines are 
2 to 4 years – 7.5 ml b.d 
4 to 7 years – 15 ml b.d 
7 to 10 years – 30 ml b.d 
 Line of Treatment: 
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 Siddha treatment is not only for complete healing but also prevention and 
rejuvenation. Saint Thiruvalluvar says about physician’s duty, study the disease, study the 
cause, treat subsiding way and do what is proper and effect. 
 ‘Neha; ehb Neha; Kjy; ehb mJ jzpf;Fk; 
 tha;ehb tha;g;gr; nray’;. 
 ‘cw;whd sTk; gpzpasTq; fhyKq; 
 fw;whd; fUjpr; nray;.” 
     - jpUf;Fws; 
 So it is essential to know the disease, the etiology, the nature of patients, severity 
of the illness, the seasons and the time of occurrence. 
Line of treatment is as follows. 
a. Kaappu (Prevention) 
b. Neekkam (Treatment) 
c.Niraivu (Restoration) 
a. Kaappu (Prevention):  
Prevention and cure of the diseases are the basic principle of any medical system, 
but prevention is the main aim of Siddha system. Siddhars have described general 
preventive measures and special measures. (Which are applicable to diseases of certain 
organs) 
            And especially in Balavagadam, the preventive measures are explained in detail. 
Prevention of the disease of the child starts from the conception and goes on as the child 
grows up in intra uterine life and after delivery.  Siddhars have dealt elaborately with the 
diet of pregnant women, her habit, the medicine to be taken in every month, her 
psychological conditions, and surroundings etc. 
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 b. Neekam: (Treatment) 
The aim of treatment is based on, 
· To bring the three thodams into normal equilibrium state, emetics and purgatives 
are given. But considering physical condition of the children administration of 
purgatives and emetics is excluded from line of treatment. 
To treat the patient according to the symptoms by internal medicine “Silethuma 
      sura kudineer”. 
c. Niraivu: (Restoration) 
· Reassurance of disease recovery was given to all patients. 
· All the patients are advised to follow the life style that provides a disease free 
life.  
9. Pathiyam (Diet): 
 During the course of treatment, the drug is administered to the patients according 
to the nature of disease and the patients were advised to follow certain restrictions 
regarding diet and physical activities. 
 This type of medical advice in siddha system of medicine is termed as 
“Pathiyam”. 
Importance of pathiyam is quoted as follows. 
      ‘gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
   gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy;  
   
gj;jpaNk ntw;wpjUk; gz;bjHf;F Mjypdhy; 
   gj;jpaNk cj;jpnad;W ghH”    
- NjiuaH ntz;gh 
The patient with kabasuram advised to avoid cool drinks, cold water and exposure 
to chill weather and allergens (dust, pollens, and odours)  
 During the course of treatment according to the drug administered to the patients 
and nature of the disease, the patients were advised to follow certain precautions 
regarding diet and physical activities. This type of medical advice in Siddha system of 
medicine is termed as Pathiyam.  
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Siddhars advice regarding the diet regimen for Kaba patients is explained below: 
Siddhars advised to avoid certain food items in Kaba and Pitha noigal. They are 
given  below:  
fj;jhp 
     mtiu 
ghfy; 
fsh 
mj;jpf;fha; 
gPHf;;fqfha; 
fjypj; jz;L 
Ks;sq;fp 
fUk;G 
g+rpdpf;fha 
cs;sp 
 ‘fj;jhp Nga;Gly tiu apUghfy; gUq;fsh fz;lfhhp 
  mj;jpf; fha;fSk; tUf;ifkhgaw;iw fiuahy; gPHf;fUk; -gpQ;RNtH 
 nkha;j;j R+uzq; fjypj; jz;Lfisg; g+Ksq;fp KUf;fUk;Gk; 
  mj;jpg; g+rpdpf; fhaUs;sp ts;spAq; fgj;NjhHf; fhzkhNk” 
‘Ntis kzj;jf;fhsp nkd; rPij rf;utHj;jp 
  gPis triy Rf;F ngz;Rzq;fs; - Ntisapiy 
 nre;jspH fisf; fPiu nra;tH fgNjfH epjk; 
  te;jdpAzj;jhd; kfpo;e;J” 
- gjhHj;j Fz rpe;jhkzp 
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10.Preventive methods: 
 The patients were advised, 
· To find out which agent makes allergy and avoid them. 
· To avoid contaminated food and water. 
· To avoid cold weather. 
· To avoid cold food stuffs, beverages etc. 
· To take highly nutritious diet like vegetable soups to get their immunity 
developed. 
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3.b. MODERN ASPECTS 
 ACUTE BRONCHITIS 
Acute bronchitis is a clinical syndrome produced by inflammation of the trachea, 
bronchi.  In children, acute bronchitis usually occurs in association with Viral respiratory 
tract infection.  
1.Bronchitis 
 Bronchitis means that the tubes that carry air to the Lungs (the bronchial tubes) 
are inflamed and irritated and it causes the tubes swell and produce mucus. 
2.Two types of Bronchitis: 
                a.Acute Bronchitis 
b.Chronic Bronchitis 
a.Acute Bronchitis 
 Acute bronchitis usually comes on quickly and gets better after 2 to 3 weeks . 
Most healthy people who get acute bronchitis get better without any problems. 
b.Chronic Bronchitis History of cough for a long period (3consecutive months in a year 
for more than 2 successive years) with sputum. Late development of wheeze and 
breathlessness are present. 
3.Aetiology 
Infection;  Acute bronchitis is most  caused by a type of germ called a Virus. It may also 
be caused by bacteria, yeast or a fungus. 
Polluted air: Child breathes air that has chemical fumes, dust or pollution. 
Cigarette smoke: If smoke around child, may be at higher risk for acute bronchitis. 
Medical Problems : Child may be more likely to get bronchitis, if he has other medical 
problems like asthma, frequent swollen tonsil, allergies, heart problems. 
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Premature birth: Bables who are premature may be at higher risk for bronchitis 
4.SIGNS AND SYMPTOMPS: 
· Cough may be dry (or) productive cough. 
· Fever, chills, body aches. 
· Sore throat, runny (or) stuffy nose. 
· Wheezing.  
· Malaise. 
· Constipation.                
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6.Pathogenesis of Bronchitis: 
 
  Pathophysiology 
Microorganism enter respiratory tract by droplet inhalation 
 
Widespread inflammation occurs [increased goblets cells squamous metaplasia of 
columnar epithelium, acute leucocytic and lymphocytic infiltration of bronchial wall] 
 
Thin mucous lining of bronchi can become irritated and swollen 
 
Cells that make up this lining may leak fluids in responses to the inflammation. 
 
Coughing as a reflex that works to clear secretions from the lungs. 
 
Alveolar fluid increases 
 
Narrowing of airways 
 
Ventillation decreases as secretion thickens  
 
Mucus within the airways produces resistance in small airways and can cause severe 
ventilation perfusion imbalance. 
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Acute bronchitis is common and most often due to infection with one of the 
respiratory virus. The inflammation causes  tightness of the chest and a rasping cough. 
         The mucous membrane of the trachea and large bronchi is red,swollen and covered 
with tenacious exudates which may be mucoid or purulent. 
        Acute bronchitis lead to the hacking cough and phlegm production that follows 
upper respiratory tract infection .This occurs because of the inflammatory response of the 
mucous membranes within  the lungs bronchial passages.Viruses acting alone or together 
accout for most of these infections.If the patient is in otherwise  good health, the mucous 
membrane return to normal,heralding recovery from the initial active infect. 
            Microscopically the mucosa is greatly congested and infiltrated and leucocytes. 
The letter are often of mononuclear rather than  polymorphonuclear type.The ciliated 
epithelium may be desquamated and mucous glands are distended with mucus and show 
marked catarrhal changes.The lumen of the bronchi is filled with pus. 
             Bronchitis follows either an endogenous response to acute airway injury or 
continuous exposure to certain noxious environmental agents [allergens]. An airway that 
undergoes such as insult responds quickly with bronchospasm and cough,followed by 
inflammation,cough and mucus production. 
               Mucociliary clearance is an important primary innate defense mechanism that 
protects the lungs from the harmfull effect of inhaled pollutants,allergens and 
pathogens.Mucociliary dysfunction is a feature of acute and chronic airway disease states 
in human.The mucociliary apparatus consists of 3 functional compartments,cilia, a 
productive mucus layer,and an airway surface liquid layer,which work together to remove 
inhaled particles from lung.Animal study data have identified a critical role for ASL 
dehydration in the pathogenesis of mucociliary dysfunction and chronic airway disease. 
ASL depletion resulted in reduced mucus clearance and histologic signs of chronic airway 
disease, including mucus obstruction,goblets cell hyperplasia and chronic inflammatory 
cell infiltration. 
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7. Physical Exam: Findings of Acute Bronchitis 
Inspection 
· Shape of the chest bilaterally symmetrical 
· Respiratory Muscles move with respiration 
· No Mediastinal Displacement 
· No Scoliosis and Kyphosis 
· No Intercostel indrawing 
· No Infra Clavicular resection 
· No Grunting of respiration 
· No Other pulsation 
 
Palpation 
· Apex beat – present in Left V intercostal space ½ inch medial to mid- 
clavicular line 
· Trachea present in midline 
Percussion 
· Resonant (Normal Finding) 
· No other Thrills 
· No other added sounds. 
Ausculation 
 Bilateral entry of air equal on both king fields.  Wheezing, wide spread rhonci, 
Consolidation, prolonged expiratory is the ausculatory findings. 
Medical Attention for Acute Bronchitis 
 Severe wheezing that makes it difficult to breathe. Worsening the Cough 
symptoms after a week, blood-tinged phlegm. A mild fever is last longer than 3 days or a 
fever over 101.F, children having chronic lung or heart condition, may have a chance of 
devloping complications. 
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8.DIFFERENTIAL DIAGNOSIS: 
Acute bronchitis should be distinguished from, 
A) Chronic bronchitis: 
History of cough for a long period (3consecutive months in a year for more than 2 
successive years) with sputum. Late development of wheeze and breathlessness are 
present.Family history is absent. 
b) Asthmatic bronchitis: 
Attack is characterised by marked dyspnea, cough, expiratory wheezing, cyanosis, 
pallor, sweating, exhaustion and restlessness are often present.It is seriously considered if 
cough occurs in early morning. 
c) Pneumonia: 
   Both bacterial  and viral are invariably accompanied by cough, fever, varying 
degrees of respiratory distress .On auscultaton, crepitation may be present.Decreased 
breath sounds with localised crepitation and dullness note favour  consolidation.In viral 
pneumonia are not as severe as in bacterial pneumonia. 
9. COMPLICATION: 
1. Pneumonia 
2. Chronic bronchitis 
3. Acute exacerbation of bronchial asthma 
4. Sinusitis 
5. Otitis media. 
Diagnosis 
· The diagnosis of bronchitis is generally clinical, based on the history & 
finding of the physical examination. 
· Labarotary Investigation 
           Raised WBC 
          CRP (Due to bacterial infection) indicates inflammation. 
· Sputum Examination 
a. Presence of Neutrophil granulocytes (inflammatory WBC) 
b. Sputum Culture Showing Pathogenic Micro Organisms. Eg. Streptococcus 
Species. 
· X-ray – Hyper inflation of bronchial vessels.  
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3c. DRUG REVIEW 
 
Ány£Lk Ru¡FoÚ® 
· g‰glhf« 
· ÓªÂš 
· R¡F 
· nfhiu¡»H§F 
· ngŒ¥òlš 
1. g‰glhf« - Parpadakam 
Botanical Name - Mollugo cerviana 
ntWbga®   -  Ój«, g‰glhf« 
English Name   -  Pever plant 
Hindi Name   -  Taph – jhad 
ga‹gL« cW¥ò –  ó©L 
Rit    –  if¥ò 
j‹ik   –  bt¥g« 
ÃçÎ    -   fh®¥ò 
Ïd«    -   ó©L 
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brŒif :  
kyäs¡» 
gÁ¤Ô¤Jh©o 
mGfyf‰¿ 
éa®it¥bgU¡» 
Fz« 
· Ïjdhš RunehŒfŸ, bt¿ nehŒfŸ, jhf«, Ã¤j« ngh«. éê¡F¡ 
Fë®¢Áia c©lh¡F«. 
· Ïij Kiw¥go FoÚç£L¡ bfhL¡f RuªjâÍ«. nkY« Nyf 
mG¡if btë¥gL¤J«. 
· Ïj‹ ntiu v©bzæš ngh£L¡ fhŒ¢Á ÑšthÍ Kjèa 
Å¡f§fS¡F njŒ¡fyh«. 
· Ïij Úçš Cwit¤J¡ bfhL¡f Ú® vç¢rš, f©bzç¢rš 
ÔU«. j§»a Nyf mG¡F btë¥gL«. 
· Ïjid¥ ghš é£liu¤J¤ jiy¡F¤ jlé Á¿J neu§fê¤J 
Ú®é£L Kœ»l f©bzç¢rš Ú§»¡ f©fŸ Fë®¢ÁailÍ«. 
“ Ójth j¢RuKª Ôuhj jhfK«ngh« 
nghjéU f©FëU« bgthŒayny ójy¤JŸ 
t‰gh® gæ¤ÂaK khÃ¤j KªbjhiyÍ« 
g‰ghl f¤ijÍ‹å¥ (gh®).” 
                   - mf¤Âa® Fzyhfl« 
Phyto Chemicals: 
· Alkaloids  
· Carbohydrates 
· Saponins 
· Tannins 
· Steroids 
· Flavanoids 
· Glycosides 
· Proteins 
· Tritenpenoid 
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Antimicrobial Properties 
The methanol extract & n-butanol fraction from the plant of Mollugo cerviana 
have antimicrobial properties, which explains the basis for its use in traditional medicine 
to treat infected wounds and  active principles against microorganism. 
[International journal of Pharmaceutical chemical sciences. Vol.1(1), Jan-Mar2012]  
Hepatoprotective activity 
It has hepatoprotective activity and trace is regenerative activity with the liver 
cells. 
[International journal of Pharmaceutical chemical sciences. Vol.2(2), 2011,176-179] 
Other properties: 
 Triterpenoids are well known to have anti inflammatory activity. This plant is 
used in traditional Indian medicine as an anti-inflammatory agent and traditional remedy 
for Rhumatism. 
 Tannins are known for their astringent property, antimicrobial activity, anti-
inflammatory. 
 Saponins are known for their medicinal properties as a natural blood cleanser, 
expectorant & antibiotics. It is used to treat fever & to purify blood. 
 Alkaloids are known to have significant physiological activities by acting mainly 
on central nervous system. 
[International journal of Green pharmacy, year 2010,Vol.4, issue-1, page.22-28] 
2. ÓªÂš - Seenthil 
Botanical Name : Tinospora cordifolia 
ntWbga® : mä®jtš, nrhktšè, mä®ij, mä®j¡bfho, F©lè 
English Name : Heart leaved moon sead, Tinospora 
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Hindi Name : Gul-bc 
Ïd« - bfho 
ga‹gL« cW¥ò -  Ïiy, bfho, nt® (»H§F) 
Rit – if¥ò 
j‹ik – bt¥g« 
ÃçÎ – fh®¥ò 
brŒif  
 clšnj‰¿ 
 Kiw bt¥gf‰¿ 
 fhk«bgU¡» 
 cŸsHyh‰¿ 
 bt¥gK©lh¡» 
 gÁ¤Ô¤Jh©o 
 cukh¡» 
 ÁWÚ®¥bgU¡» (brh‰g) 
Ïiy 
 Ïiyia mdèš th£o¥ ò©fë‹ ÛJ ngh£Ltu ò©fŸ fiuªJ 
Ó¡»u¤Âš Fz¥gL«. 
“ bgh‰ÓªÂ è‹»H§F bgh§F kJnkf« 
  V¢Rfa nuhf« Ïis¥òél« - g¢irahŒ 
  Xou¤j Ã¤j« ca®Ru§f is¡fisÍª 
  njlça nkåjUŠ nr®” 
       - mf¤Âa® Fzthfl« 
  bgh‰ÓªÂš »H§»dhš ÚçêÎ, Ïis¥ò nehŒ, Ru«, eŠRfŸ, FUÂaHš 
nehŒ ngh«. fhaÁ¤Â c©lhF«. 
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bfho 
 K‰¿a bfhona e‰ga‹ jU«. Ïjdhš clš t‹ik bgW«. 
 Ïj‰Fça brŒiffŸ ahÎ« F‹whÂU¡f nt©o‹ Ï¡bfhoæš if¥ò 
äf nt©L«. Ï¡Fznk‰gLtj‰F¡ bfho KÂu nt©L«. KÂ®ªj bfhoia¡ 
nfhil¡fhy¤Âš nrfç¡f nt©L«. k‰w¡ fhy§fëš nrfç¡f¥gLtj‰F 
Ï¡Fz« ãiwªÂuhJ. 
 ÓªÂš kJnkf bk‹W« ÚçêÎ nehæY©lhF« Ú® nt£ifia¤ jâ¡F«. 
 Ï¡bfhoæèUªJ vL¡F« c¥ò¡F ÓªÂš r®¡fiu v‹gJ bga®. ÏJ 
gÂbd© tifahd Fiw nehŒfS«, ahid¤njhš ngh‹w brh¿Í«, bfhoa 
fg¥ÃâfS« ÓªÂš c¥ig¡ bfhL¡»š xêÍ«. ÏJ ÁWÚ®¥igæ‹ 
jhÃj§fS¡F äf¢ ÁwªjJ. 
Phyto Chemicals 
Alkaloids 
 Berbeine, Palmotine, Tembetarine, Magnoflorine, Choline, Tinosporin, 
Isocolumbine Palmitine Glycosides in Stem. 
Whole Plant – Furanolactone, Tinosporon, Heptacoranol Octacosanol 
Steroids – Aerial Part, Stem 
 - B Sitosterol, S Sitosterol 
  [Indian Journal of Pharmacology 2003;35;83-91] 
Constituents: 
 The active adaptogenic constituents are ditrepene compounds including tinospora, 
tinosporic acid, cordifolisides A to E berberine, Giloin, Crude giloiniraid, a glucoridel 
bitter painciple as well as polysaccharides. 
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Immunomodulator Activity: 
 Immunomodulator are natural or synthetic agents, which by modfying the 
immume system affect a therapeutic benefit. They may have ability to restore, inhibit or 
help to produce the desired immune isponse. The work described that Tinospora 
cordifolia alcoholic extract shows immunomodular activity. 
Hepatoprotective: 
Tinospore is effective in preventing the hepato toxicity, which is protecting the 
liver from damage. 
Antipyrectic Activity 
Dry barks of T. cordifilia has antipretic activity. 
Medicinal uses 
 It cures fever, Jaundice, trirst, burning sensation, diabetes, piles, skin ailments, 
respiratory disorders, neurotical problems and improves intellect. It is also used in case of 
spermatoerhoea, phosphaturia diseasesof genitor- urinary tract such as dysuria, 
gonorrhoea, chronic cystitis, gout, impotence also in uterine disorders after parturition. 
[Vaibhavd aher, Arunkumar wahi international journal of current 
pharmacological research vol.2 issue 4 2010] 
3. R¡F 
Botanical Name – Zingiber officinale 
ntWbga®  
 mU¡f‹, mjf«, M®¤uf«, cgFšy«, cy®ªj ÏŠÁ, fLg¤Âu«, R©o, 
brh©o, brsg‹d«, brst®z«, etRW, ehfu«, kbesõj«, é¢tngõ#«, 
élKoa mä®j«, nt®¡bfh«ò. 
English Name : Dried Ginger 
Hindi Name : Sonth 
 - 41 - 
ga‹ cW¥ò - »H§F (cy®ªjJ) 
Rit – fh®¥ò 
j‹ik – bt¥g« 
ÃçÎ – fh®¥ò 
brŒif 
 bt¥gK©lh¡» 
 gÁ¤Ô¤Jh©o 
 mf£LthŒyf‰¿ 
  “ Niykªj« beŠbrç¥ò njhlnk¥ g«kHiy 
   _y« Ïiu¥ÃUkš _¡FÚ®   - thyfg 
  njhlkÂ rhuª bjhl®thj F‹kÚ®¤ 
   njhl«M k«ngh¡F§ R¡F.” 
        - mf¤Âa® Fzthlf« 
 R¡»dhš brçaik, kh®bgç¢rš, òëna¥g«, bt¥g«, ÑœthŒ nehŒ, Ïiu¥ò 
ÏUkš, fê¢rš, Únu‰w«, F‹k«, tæ‰W¥Ãr«, fhJF¤jš, KfnehŒ, jiynehŒ, 
Fiytè, gh©L, tæ‰W¡F¤jš IaRu« ngh«. 
Chemical Constituents 
 Volatile Oils (bisabolene, borneol, Camphene, Cineol, Citral, Citronelrol, 
Seranial, limonene, linalogl, Phellandrene, Zingibereene, Zingiberol) The aromatic 
principles are bisabolene & Zingiberene. 
 The pungent principles are gingerols & Shoguols which are anti-nausea, 
Gingertols turn into shogaols when exposed to heat and air. 
 - 42 - 
Other ingredients, Calcium, Capsaicin,  high in iron and Calcium, linoleic acid 
Magnesium, Phosphorous, Potassium, riboglavin, Vitamin B & Vitamin C, Zingibain, 
Ginger has proteases. 
 http:// www. Medicinetyourfeet.com/ZingiberofficinaleCiral 
Following Studies were already done in Chukku: 
I. Antibacterial Activity 
 Zingibain enhances antibacterial and anti-inflammatory actions and it is thaught to 
assist other antibacterials such as antibiotics by up to 50%. Dried Ginger ability to redue 
inflammation is due to its neutralizing action upon free radicals which are known to 
contribute to the problem. Finally, Ginger contains over it antioxidant constitulents the 
combined action of which have been regarded as being more powerful than vitamin C 
2. Anti-infammatory Action 
 Dried ginger extract inhibited carrageenan-induced paw swelling and was an 
active as aspire. Essential oil of ginger injibited chronic adjuvant arthritis in rats ginger 
and its pungent components are dual injibitors of arachiodonic acid metasolism.  
3. Antipyretic Activity 
Dried ginger extract given orally reduce fever in rats by 35%, while the same dose 
of aspirin was effective by 15%. The antipyretic activity of 6 Shogaol urel 6-gingeroil has 
also been observed. 
4. Antioxidiant Activity 
 Extracts of dried ginger have pronounced antioxidant activity comparable to that 
of synthetic antioxidant preservatives. 
 Phyto Chemicals 
ÏÂš Phellandrene, Gingerol Kjèa bl®Õ‹fŸ cila eWkz v©bzŒ cŸsJ. 
nkY« K¡» ntÂ¥ bgUshd  v‹D« xènah buÁ‹ cŸsJ. 
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4. nfhiu¡»H§F 
Botanical Name – Cyperus rotundus 
Ïd« - òšèd« 
English Name – Nut glass 
Hindi Name - Mutna 
Ïd« - òšèd« 
brŒif   
Jt®¥Ã 
 bt¥gK©lh¡» 
 cukh¡» 
 ÁWÚ®¥bgU¡» 
 éa®it bgU¡» 
 cŸsHyh‰¿ 
 UJÎ©lh¡» 
 òGtf‰¿ 
Fz« 
  “ ÓjRuªÔ®¡FŠ br«òdšÃ¤ j«nghF« 
   thj Ruªjâ¡F« itaf¤Âš – niyijbrŒa 
  tªj Ãâiabašyh« th£L K¤j¡fhR 
   bfhªjyÍ« th®FHny! TW 
  mÂfhu« Ã¤j« bfhoa – KÂ®thªÂ 
   ahiu¤ bjhl®ªjhY« m›tt®¡bf yh§Fs¤J¡ 
  nfhiu¡ »H§if¡ bfhL.” 
       - mf¤Âa® Fzthfl« 
Ïjdhš eë®¢Ru«, FUÂaHš nehŒ, Ru tiffŸ, Ú®nt£il, K¥Ãâ, 
fê¢rš, gæ¤Âanjhl«, Ã¤jjhf«, fgnuhf«, FÂ¡fhiy¥ g‰¿a thÍ, thªÂ 
ÏitfŸ ngh«. 
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kU¤J r¤J¡fŸ 
 nt®»H§»š Starch, Carbohydrete k‰W« Pineapple, Cineole, M»a 
bl®Õ‹fŸ ml§»a eWkz v©bzÍ«, Glycerol, Linolenic Acid, Oleicaid  M»a 
bfhG¥ò v©bzÍ« cŸsd. 
Chemical Constituents 
 Cyperone, Selinene Cuperene, Sugeronol, Cypertundone. 
Following Studies were already done in Korai Kizhangu 
 Modern alternative medicine recommends using the plant to treat nausea, fever 
and inflammation for pain reduction, for muscle relaxation and many other disorders. 
 En.wikipedia. org/Wiki/Cyperus Rotundus 
Anti inflammatory activity of cyperus rotundus in acute models of inflammation 
 In the model of carrageenam induced paw edema cyperus rotundus showed a trend 
to reduce the edeme while the combination of Pe + Pz (PI:20.64%) showed results 
comparable to aspirin (23.74%). 
Antiviral Acitivity 
 Cyperus rotundus are found to have virucided effect against HSV. 
 19666102 (Puppmed-indexed for MEDICINE). 
5. ngŒòlš 
 ga‹gL« cW¥ò-fhŒ 
 Rit -Ïå¥ò 
 j‹ik -j£g« 
 ÃçÎ-Ïå¥ò 
brŒif-Fë®¢ÁÍ©lh¡» 
 -fhk«bgU¡» 
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Botanical Name : Trichosanthas cucurmine 
English Name  : Snake Gourd 
The Phytochemical screening of trichosaritres cucumerine, The extracts has 
revealed the presence of various secondary metabolites of therapeutic importance, namely 
alkaloids, flavanoids, cardiac glycosides, phenols, sterols,tannin, saponins, lignans. 
 The result of the successive extracts at 4 mg/1ml and is comparison with standard 
antibiotic streptomycin 1mg/ml was recorded. 
Antimicrobial property: 
 Several works have reported that it posses antimicrobial properties including 
flower, bark, stem, leaf shown that when solvents like ethanol, hexane and methanol are 
used to extract plants, most of them are able to exhibit inhibitory effect on both gram 
positive and gram negative bacteria. 
 [Advances in natural and applied sciences – September 1, 2009] 
Anti-oxidant Activity: 
 It has antioxidant property while it contains ascorbic acid, lycopene, phends, 
flowories. 
(Afr J Tradit complement alterm med. 2008.5(2).173-179) 
· A study of antioxidant, Analgesic and anti nuclear potential of trichosantres 
cucumerine etranotic seeds extract – Asian Journal of plant sciences, 11:235-240 
· Flavoroids exhibit varoprotective, anti-inflomentory, anti-allergic, antimicrobial, 
antioxidant, hepatoprotective, anti osteoporotic and anti-reoplastic properties. 
[chinmed.2012;7:12] 
(Semin Respir infect 1994,mar, 9(1);8-12. prepared 
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4. MATERIALS AND METHODS 
4.1 Preparation of silaethuma sura kudineer 
The required drugs for preparation of silaethuma sura kudineer will be purchased from a well 
reputed country shop and raw drugs are authenticated by the help of   Dept HOD and Herbal 
botanist and with Department of Gunapadam. The  medicine  will be  prepared in Gunapadam lab 
of National institute of Siddha after proper purification. The  medicine  was   prepared in 
Gunapadam lab of National institute of Siddha after proper purification. The prepared medicine  
also authenticated by the  Head of the Department. 
INGREDIENTS: 
VERNACULAR TAMIL NAME     BOTANICAL NAME        WEIGHT 
  Seenthil   Tinospora cordifolia Linn  12gm 
Parpadagam            Mollugo cerviana   Linn  12gm 
Paipudal    Trichosanthes lobata Linn          12gm     
         Muthakasu   Cyprus rotundus Linn   12gm 
Chukku   Zingiber officinale Linn  12gm 
PURIFICATION & PREPARTION : 
Chukku soaked in lime water filtrate and remove the outer layer ,parpadagam,paipudal, 
muthakasu – dried in sun light .Seenthil  – remove the outer layer of the root and cut in to small 
pieces  &dried it sun light.        
All purified drugs were  grinded into a coarse powder. Divided in to 3 parts. Add  
2 nazhi (2.6lit) of water into each part, boiled upto 1/8 of it is original and filter it .. 
Dosage:  
2 to 3 years – 7.5ml [bid]     
4 to 6 years -  15ml [bid]      
7 to 10years – 30ml [bid]  for 3 days. 
          Adjuvant: Honey 
Indication: kabasuram, 
DRUG STORAGE:  
      The trial drug Silethuma Sura Kudineer is  stored in clean and dry air tight container. 
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SILAETHUMASURAKUDINEER CHOORANAM 
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4.2 Preclinical Studies 
4.2.1 Preliminary phytochemical screening of SSK 
The preliminary qualitative phytochemical screening of KKC was done by the method of  Kolkate (1) 
Preliminary  Qualitative analysis of drug – SSK 
Procedure 
Test for Calcium : 2 ml of extract is taken in a clean test tube. To this add 2 ml of  4% 
ammonium oxide solution.   
Test for Sulphate : 2 ml of the extract is added to 5 % barium chloride solution. 
Test for Chloride : The extract is treated with Silver nitrate solution  
Test for carbonate : The substance is treated with Conc. HCl. 
Test for Starch : The extract is added with weak iodine solution  
Test for Iron (Ferric) : The extract is treated with glacial acetic acid and potassium ferrocyanide  
Test for Iron (Ferrous) : The extract is treated with Conc. HNO3 and ammonium thiocynate 
Test for phosphate : The extract is treated with ammonium molybdate and conc. HNO3 
Test for Tannic acid : The extract is treated with Ferric chloride  
Test for Unsaturation : 1 ml of Potassium permanganate solution is added to the extract.    
Test for saponins: Dilute extract+ 1ml of distilled water shake well. 
Test for sugars :  
 Benedict method ; 5ml of  Benedict solution heated gently then add 8 drops of diluted extract 
then heated in a boiling water bath. 
Molisch test; Dilute extract+2 drops of Molisch+3ml conc.H2SO4. 
Test for steroids : Liberman Burchard test ; Dilute extract +2 ml acetic anhydride+conc.H2SO4 . 
Test for amino acids: Dilute extract +2ml of Ninhydrin’s soln . 
Test for proteins: Biuret method ; 1ml of dilute extract+1mlof5%CuSO4+1%NaOH. 
Test for Flavanoids : Dilute extract+ mg  bits+2drops of conc.HCl  and gently heated. 
Test for phenol; Dilute extract+2drops of FeCl3 soln. 
Test for Tannins ; dilute extract +2ml of 10%lead acetate add. 
Test for alkaloids; 
 Mayer’s method;1ml of dilute extract + 1ml reagent. 
Dragendroff’s method; 1ml of dilute extract+ 1ml of reagent. 
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4.2.2 Toxicity studies 
 The preclinical studies for acute toxicity was carried out in  Pharmacological 
laboratory in National institute of Siddha with the reference number of IAEC protocol 
no:1248/ac/09/CPCSEA and subacute toxicity studies were done in C.L.BAID MEHTA 
COLLEGE OF PHARMACY. 
4.2.2.1 Drugs and chemicals 
 All fine chemicals used in these experiments were obtained from Sigma 
Chemicals company, U.S.A. Other analytical grade chemicals were obtained from S.d. 
Fine Chemicals Ltd., Mumbai. TAB vaccine is obtained from Serum Institute, Pune 
4.2.2.2 Experimental animals  
 Colony inbred animals strains of wistar rats of either sex weighing 200 - 250 g 
were used for the pharmacological and toxicological studies. The animals were kept 
under standard conditions 12:12 (day/night cycles) at 220C room temperature, in 
polypropylene cages. The animals were fed on standard pelleted diet (TANUVAS, 
Chennai) and tap water ad libitum. The animals were housed for one week in 
polypropylene cages prior to the experiments to acclimatize to laboratory conditions. The 
experimental protocol was approved by the Institutional Animal Ethical Committee 
(IAEC). (IAEC/XXXV/92/ CLBMCP/2012) 
4.2.2.3. Acute oral toxicity study     
Acute oral toxicity was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute 
toxic class method is a stepwise procedure with 3 animals of a single sex per step. 
Depending on the mortality and /or moribund status of the animals, on the average 2-4 
steps may be necessary to allow judgment on the acute toxicity of the test substance. This 
procedure results in the use of a minimal number of animals while allowing for 
acceptable data based scientific conclusion. 
The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity 
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Wistar albino rats of either sex weighing 200-250 g were fasted overnight, but 
allowed water ad libitum. Since the formulation is relatively nontoxic in clinical practice 
the highest dose of 2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) was used in 
the acute toxicity study.   
The animals were observed closely for behavioral toxicity, if any by using FOB 
(Functional observation battery). 
4.2.2.4 Repeated oral toxicity study  
Repeated oral toxicity studies can be used to get additional information regarding 
the toxicity profile of a chemical. Repeated oral toxicity studies are defined as those 
studies where the chemical is administered to the animal for a period covering 
approximately 10% of the expected life of the animal. Usually, the dose levels are lower 
than for acute studies and allow chemicals to accumulate in the body before lethality 
occurs, if the chemical possess this ability. 
4.2.2.5 Experimental procedure 
The following experimental procedure was followed to evaluate the repeated oral 
toxicity study of  
Group I : Control animals received 1%CMC (Sodium carboxy methyl cellulose), 10 
ml/kg/p.o.  
for 14 days  
Group II : Suspension of SSK in CMC at the dose Level of 2.7ml/kg/p.o for 14 days 
The dose for rats was calculated from the daily human dose recommended divided 
by a factor 0.018 according to the body surface area for a rat weighing 200g 
Dose Calculation: 
Recommended daily dose for human is 30ml.Convert the human dose to rat dose 
by multiplying the human dose with a factor 0.018 to get a rat dose for rat weighing 200g. 
Multiply the 200g rat dose x5 to get the rat dose for Kg body weight 30ml x 
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0.018=0.54ml for 200g body weight rat .Multiply with 5 to get rat dose for 1kg body 
weight i.e.0,54 x 5=2.7ml for kg body weight rat. 
 Body weight, food intake and water intake was recorded at two intervals with 
simultaneous observation for toxic manifestation and mortality, if any. At the end of 21 
days treatment all the animals were sacrificed by over dosage of ether anesthesia. Blood 
was collected and used for hematological studies. Section of liver, kidney, and heart were 
dissected out and kept in 10% formalin for histopathological studies. 
4.2.2.6 Biochemical studies 
Aspartate aminotransferase (AST) 
 Aspartate aminotransferase was estimated using commercial AST kit (Span 
Diagnostics) by the method of Reitman and Frankel (2). 
Alanine aminotransferase (ALT) 
 Alanine aminotransferase was estimated using commercial AST kit (Span 
Diagnostics) by the method of Reitman and Frankel (2). 
Alkaline phosphatase (ALP) 
 Alkaline phosphatase was assayed using commercial ALP kit (Span Diagnostics)  
by the method of King (3). 
Urea, BUN, Glucose, Cholesterol   
 Urea, BUN, Glucose and cholesterol were assayed using the commercial kit (Span 
Diagnostics) . 
4.2.2.7Haematological studies 
Erythrocyte count 
 Erythocyte count was estimated by Hemocytometer method of Ghai (5). 
Total Leukocyte Count (WBC) 
 Total Leukocyte Count was estimated by Hemocytometer method of John (6). 
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Haemoglobin  
 Haemoglobin was estimated by method of Ghai (5). 
4.2.2.8 Histopathological studies  
 Animals were sacrificed at the end of repeated oral toxicity and tissues were 
processed for histopathological studies. 
4.2.3 Analgesic activity   
Hot plate test(Eddy’s method- Vogel (2002)(6) 
 The test was performed using Eddy’s hot plate maintained at a temperature of  55 
± 1°C.  .  The basal reaction time of all animals was recorded.  The animals which 
showed fore paw licking or jumping response within 6-8 secs were selected for the study. 
60 min after the administration of test and reference compounds, the animals in all the six 
groups were individually exposed to the hot plate maintained at 55 C. The time taken in 
secs for fore paw licking or jumping was taken as reaction time. A cut off period of 15 
secs is observed to avoid damage to the paws. Analgesic activity was recorded at hourly 
intervals of 2 hours after drug administration. 
4.2.4Antipyretic activity (6) 
Rats selected for the study were fasted overnight allowing water ad libitum. Initial 
rectal temperature was recorded using Hick’s clinical thermometer. Pyrexia was induced 
by subcutaneous injection of TAB vaccine 1 ml/kg body weight. Six hrs later pyrexia was 
assessed and those animals that did not show a minimum rise of 1.5oC were rejected.  The 
animals thus found fit for the study were divided into 6 groups as described above and 
drugs were administered.  Pyrexia was recorded at hourly intervals for 3 hrs after drug 
administration.  
4.2.5 Anti inflammatory activity-Winter et.al(7)  
 Anti inflammatory activity of SSK was evaluated in both acute and chronic 
models of inflammation.  
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4.3 Clinical studies 
Kabasuram  is one of the frequently encountered problem among young children.               
A  protocol was prepared and submitted before IEC meeting, a copy of  which is attached as 
annexure-1. After that 40 cases were selected for clinical trial from the OPD and IPD of 
Kuzhandhai Maruthuvam department National institute of Siddha. 
            Study Type :         
           An open clinical trial 
Study place :  
           OPD. & IPD. Of Ayothidass pandithar hospital, 
                      National Institute of Siddha ,  
           Tambaram sanatorium, Chennai-47. 
  Study period :  
 12 months                                                                                                                                                               
· POPULATION AND SAMPLE  2-10 years age group fulfilled the 
inclusion criteria and exclusion criteria. 
· The sample consists of patients attended the OPD of Ayothidoss Pandithar 
Hospital, National Institute of Siddha, Chennai-47. 
          Sample size 
                  40 children   
SUBJECT SELECTION  
As and when patients  reported with symptoms of kabasuram and fulfilled the 
inclusion criteria were subjected to screening test and documented using screening 
proforma.                    
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Inclusion Criteria 
· Age 2 to 10years  
· Children, who  complained the symptoms like  
 Fever, 
 Difficulty in breathing 
 Dry or productive cough 
 Head ache,  
Constipation,  
Running nose,   
Malaise,  
Polyarthralgia.  
· Willing to give specimen of blood for investigation when required. 
· Willing to attend the OPD on fourth day of treatment.  
EXCLUSION CRITERIA 
  a.  A patients were not eligible for admission to the trail if any following is 
applicable 
 Convulsions,  
Jaundice, 
Typhoid, Malaria, 
Active primary complex, 
Pneumonia, 
Rheumatic fever, 
Urinary tract infection. 
          b.  Patient not willing to give biological sample whenever required. 
          c.  Patient not willing to give consent for the study  
WITHDRAWAL CRITERIA 
· Exacerbation of symptoms  
· Occurrence of any adverse effect such as diarrhea, abdominal discomfort. 
· Patient turned to unwilling during the course of trial drug         
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The trial drug “Silaethumasura kudineer’’ was given continuously for 3days. For 
OP patients, they  were asked to attend the OPD on the 4th day  and they were  instructed 
to bring back unconsumed trial drugs and return them during their next visit.  At each 
clinical visit clinical assessment was done and prognosis was noted. For IP patients the 
drug was provided daily and prognosis was noted and also clinical assessment was done 
.Laboratory investigations & radiological investigation were done 0day & 15 th day of the 
trial. For IP patients, who were  not in a situation to stay in the hospital for 3 days is 
advised to attend the OPD for further follow-up. . If any trial patient who failed to collect 
the trial drug on the prescribed day but wanted  to continue in the trial from the next day 
or two, he/ she was  allowed, but defaulters of one week and more will not be allowed to 
continue and be withdrawn from    the study with fresh case being inducted. 
        Drug Storage : 
            The trial drug SSK was stored in clean and dry wide mouthed glass bottle. 
        Dispensing: 
                       The kudineer was given in powder form in packets. 
  E. ASSESSMENT AND TESTS; 
· Clinical assessment 
· Routine Investigation 
· Specific Investigation 
CLINICAL ASSESSMENT 
· Fever 
· Cough with or without expectoration  
· Breathlessness 
· Arthralgia 
· Malaise 
· Constipation 
· Head ache 
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SIDDHA METHOD OF ASSESSMENT 
· Poriyal arithal  
· Pulanal arithal 
· Vinathal  
· Uyirthathukkal  
· Udal thathukkal 
· Envagai thervugal 
· Nilam 
· Kalam 
LABORATORY INVESTIGATION; 
· Temperature  
· BLOOD TEST – TC, DC, ESR, HB, WIDAL,  
· Peripheral smear MF,MP,RA factor 
· URINE TEST – ALBUMIN, SUGAR, DEPOSIT, BS, BP, 
UROBILINOGEN 
· SPUTUM for AFB 
· CHEST – X  RAY 
STUDY ENROLLMENT 
   In this study, patients reported at the OPD with the clinical symptoms of fever, 
difficulty in breathing, dry or productive Cough, headache, running nose, constipation, 
malaise, polyarthralgia examined clinically for enrolling in this study based on the 
inclusion and exclusion criteria.  
· The enrolled patients were  informed about the study, trial drug, possible 
outcomes and the objectives of the study in the language and terms understandable 
to their  informants.. 
· After ascertaining the patients and informants willingness, informed consent 
obtained in writing from their parents in the consent form. 
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· All these patients were given unique registration card in which patient’s 
Registration number of the study, Address, Phone number and Doctors phone 
number etc. was given, so as to report easily should any complications arise. 
· Complete clinical history, complaints and duration, examination findings-- all 
were recorded in the prescribed Proforma in the history and clinical assessment 
forms separately. Screening Form- I will be filled up. Form II, and  Form –I11 
used for recording the patient’s history, clinical examination of symptoms and 
signs and laboratory investigations respectively. 
· Patient  was advised to take the trial drug and appropriate dietary advice  would be 
given according to the patients’ perfect understanding. 
DATA MANAGEMENT 
· After enrolling the patient in the study, a separate file for each patient opened 
and all forms was filed in the file. Study No. and Patient No. was entered on the 
top of file for easy identification. Whenever study patient visits OPD during the 
study period, the respective patient file was taken and necessary recordings 
were made at the assessment form or other suitable form. 
· The screening forms was filed separately. 
· The Data recordings in all forms were monitored and scrutinized by HOD, Dept 
of kuzhanthai maruthuvam, Data analysis were done with the help of senior 
research officer (statistics) of NIS. 
OUTCOME 
· Good-reduction  most of the symptoms. 
· Moderate-All symptoms are persisting. 
ADVERSE EFFECT /   SERIOUS EFFECT MANAGEMENT:         
If the trial patient develops any adverse reaction, he/she was immediately 
withdrawn from the trial and proper management  given in OPD of National Institute of 
Siddha. 
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ETHICAL.ISSUES  
· To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab 
equipments were used. 
· No other external or internal medicines were used. There was no infringement 
on the rights of patient. 
· The data collected from the patient will be kept confidentially. The patient will 
be informed about the diagnosis, treatment and follow-up.  
· After the consent of the patient (through consent form) they were enrolled in 
the study. 
· Informed consent  obtained from the patient explaining in the understandable 
language to the patient. 
· Treatment provided free of cost. 
· In conditions of treatment failure, adverse reactions, patients had given 
alternative treatment at the National Institute of Siddha with full care 
throughout the end. 
· Biochemical analysis was done [ results were attached in annexure ]. 
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5. RESULTS AND OBSERVATIONS 
5.1 Preliminary phytochemical screening of SSK 
The pre clinical qualitative phytochemical analysis of KKC showed the following result 
Observation Inference 
No white precipitate is formed Absence of calcium 
No white precipitate is formed Absence of Sulphate 
White precipitate is formed Presence of Chloride 
No effervescence is formed Absence of carbonate 
No blue colour is formed Absence of starch 
No blue colour is formed Absence of Ferric iron 
Blood red colour is formed Presence of Ferrous iron 
Yellow precipitate is formed Presence of phosphate 
Black precipitate is formed Presence of Tannic acid 
Does not get decolourised Absence of unsaturated compound 
No Froth formation Absence of saponins 
No colour change occured 
No Reddish violet zones appeared 
Indicates the Absence of sugar 
Absence of carbohydrate 
No Formation of red colour Absence of steroids 
Formation of  violet colour Presence of  amino acids 
Formation of deep blue  colour Presence of proteins 
Formation of pink colour Presence of Flavanoids 
No green colour is formed Absence of phenols 
White precipitate formed Presence of tannins 
Appears cream colour precipitate 
Appears orange colour precipitate 
Presence of alkaloids 
Presence of alkaloids 
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5.2 Preclinical studies 
Acute oral toxicity study 
The formulation is relatively nontoxic in clinical practice the highest dose of 2000 
mg/kg/p.o (as per OECD guidelines “Unclassified”) was used in the acute toxicity stud 
Effect of Siddha Formulations (SSK)on Haematological parameters after 14 days 
repeated oral dosing 2.7ml/kg/po) 
Groups Hb 
(gm/100ml) 
RBC 
(millions/cu
.mm) 
WBC 
(cells/cu.mm) 
Differential leucocyte count (%) 
Lympho 
Cytes 
Mono 
cytes 
Granulo 
cytes 
Normal 
control 
14.98  0.783 5.65  0.705 
  
5386.08  
10.44 
75.06  
3.89 
  
3.610  
0.27 
20.84   
3.267 
SSK(2.7.
ml/kg/p.o) 
14.99  0.521 
ns 
5.67  0.427 
ns 
5786.66  
7.323ns 
777.07  
3.12 ns 
3.16  
0.87 ns  
19.96  
2.74 ns 
 
n=6; Values are expressed as mean  S.E followed by Students Paired ‘T’ Test 
ns – non significant when compared to control groups  
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Effect of Siddha formulation (SSK) on Biochemical markers of liver and kidney 
after 14 days repeated oral dosing (2.7ml/kg/po) in rats  
 
N=6; Values are expressed as mean  S.D followed by Students Paired ‘t’test  
ns – non significant when compared to control groups  
Antipyretic activity of (SSK) in rats 
Pyrexia was recorded at hourly intervals for 3 hrs after drug administration.  
Groups Rectal temperature (0C) 
0 min 30 min 60 min 120 min 240 min 
ControlGroup-1 34.902.18 37.201.24 38.170.34 37.3 01.08 36.760.78 
pyretic control 
Group-2 
35.01±0.12 37.08±0.14*a 39.21±0.05**a 39.90±1.01***a 39.87±0.94***a 
Test (SSK) 
Group-3 
35.030.20 37.500.70 36.340.11***b 
35.08 
0.30***b 
37.410.33**b 
Standard (Dic.Sodium  
5 mg/kg/po) Group-4 
35.600.98 
Ns 
36.880.95 
Ns 
35.990.61***b 35.750.20***b 36.510.72**b 
n=6,  Values are expressed as mean  S.E using Student’s paired ‘t’ test. 
*P<0.05**p<0.01,***p<0.001 as compared with that of control. 
a Comparison between group-1 vs group-2 
b::omparisonbetween group -2 vs Groups 3 and 
Groups 
ALP 
(K.A.    
Units) 
AST 
(IU/L) 
ALT 
(IU/L) 
Urea 
(mg/100ml) 
BUN 
(mg/ 
100ml) 
Glucose 
mg/dl 
 
Cholestrol 
mg/dl 
Choleste
rol mg/dl 
Control 
2.8730.
332 
79.791.906 25.482.93 16.382.12 7.820.84 85.577.97 53.75±6.90ns 
53.756.9
0 
Test 
(SSK) 
2.5630.
4719  
ns 
77.203.920  
ns 
22.080.54 
ns       
17.430.083  
ns 
7.500.11  
ns 
84.4711.47 
ns 
59.78±2.37ns 
ns 
59.783.2
0  
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Analgesic activity of (SSK) using Eddy’s Hot Plate Method 
Analgesic activity was recorded at hourly intervals of 2 hours after drug administration. 
Groups Paw licking response  (Sec) 
0 min 30 min 60 min 120 min 
Control 7.260.91 7.740.96 7.66 0.61 8.81 0.53 
Test(SSK) 
2.7ml/kg/po 
7.560.1 8ns 8.82037* 9.811.44** 9.3010.07** 
Standard 
(Dic.Sodium  
5 mg/kg/po) 
7.430.89ns 8.801.11** 12.501.31*** 14.201.16*** 
 
n=6,  Values are expressed as mean  S.E using Student’s paired ‘t’ test. 
*P<0.05** p<0.01***p<0.001 as compared with that of contro 
 
Anti inflammatory activity of (SSK) in Cotton Pellet Granuloma 
Groups Cotton pellet Granuloma method 
Dry Weight (mg) 
 Untreated Control 109.87  10.42 
Test(SSK) 77.00  11.32** 
Standard (Dic.Sodium  
5 mg/kg/po) 
69.71  5.12** 
 
n=6; Values are expressed as mean  S.E comparing the values of control vs test drugs by 
Student’s  paired ‘t’ test 
**P<0.01 as compared with that of control. 
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ns – non significant when compared to control 
Effect  of SSK on Carrageenan induced hind paw edema in rats 
Treatment 0min 30min 60min 120min 240min 
Control-Group-1 0.871±0.16 0.890±0.072 0.852±0.0.117 0.901±0.083 0.872±0.764 
Edematous control-
Group-2 
0.873±.0.20 0.967±0.102**a 1.084±0.021***a 1.123±0.310***a 1.007±0.764 
Test(SSK)-Group-3 0.9210.014 0.9940.077 0.9780.042**b 0.971.280.12***b 0.8760.028**b 
Standard (Dic.Sodium 5 
mg/kg/po)Group-4 
0.8930.013ns 0.8960.067*b 1.120.072**b 0.9660.041***b 0.8760.028**b 
 
n=6; Values are expressed as mean  S.E  Values are compared with control and analyzed  
by Student’s ‘t’ test. 
**P<0.01,***p<0.001  as compared with respective  control. 
a:group 1 vs group 2 
b: group 2 vs groups 3 and 4 
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5.3 CLINICAL STUDIES 
For the clinical study 40 cases were selected and treated, in which 30 cases were treated 
in OPD and 10 cases were treated in IPD of National Institute of Siddha.  Results were observed 
with respect to the following criteria 
Results were observed with respect to the following criteria: 
· Age 
· Sex 
· Parent’s Socio Economic Status 
· Diet 
· Religion 
· Paruvakaalam 
· Uyir thathukkal 
· Ezhu udal kattugal 
· Envagaithervugal 
· Neikuri 
· Cllinical features 
· Haemotological Profile 
· Biochemical Analysis 
· Result 
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Table 1 
Distributions of patients with kabasuram according to Age Distribution 
·  
Age No of cases Percentage 
 2-4years 19 47.5 
4 -7years 9 22.5 
7-10 years 12 30 
 
 
Inference: 
 Out of 40 patients, 47.5% of cases were 2-4 years, 22.5% were 4-7 years, 30% 
were 7-10 years. 
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Table 2 
·  
Distributions of patients with kabasuram according to Gender Distribution 
 
Gender No of cases Percentage 
Male child 22 55 
Female child 18 45 
Total 40 100 
 
 
 
 
Inference: 
Out of 40 patients 55% were male children and 45% were female children   (Table 2). 
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Table 3 
Distributions of patients with Kabasuram according to 
 Parent’s Socio Economic Status 
Socio Economic Status No of  Patients Percentage (%) 
Lower Income Groups 14 35 
 Middle Income Group 18 45 
 High Income Groups 8 20 
Total 40 100 
 
 
Inference:  
 About 35% patients were under Lower Income Group, 45% patients were under 
Middle Income Group and 20% patients were under High Income Group.  The highest 
incidence occurred in middle Income Group. 
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Table 4 
Distributions of patients with kabasuram according to Diet 
Diet No of Cases Percentage 
Vegetarian 5 12.5 % 
Non vegetarian 35 87.5 % 
Total 40 100 % 
 
 
Inference:  
 According to diet, high incidence of cases (87.5%) was noted in non vegetarian 
and in vegetarian 12.5% cases were noted. (Table 4) 
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Table 5 
Distributions of patient kabasuram according to Religion 
 
Religion No of Cases Percentage 
Hindu 32           80 % 
Christians 3           7.5 % 
Muslims 5          12.5 % 
Total 40           100 % 
 
 
Inference:  
 According to Relegion, high incidence of cases (80%) was noted in Hindu. in 
Christian was 7.5%, and in Musilims-12.5% cases were noted. (Table 5) 
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Table 6 
Distributions of patients with kabasuram  according to Paruva Kalam  
(Seasonal Variation) 
Paruva kalam No. of Cases Percentage 
Karkalam 21 52.5 
Koothirkalam 4                   10 
Munpani kalam 0 0 
Pinpanikalam 0 0 
Elavenil kalam 0 0 
Muthuvenil kalam 15 37.5 
Total  40 100 
 
 
Inference: 
According to paruva kaalam, high incidence of cases (52.5%) were  noted in 
karkalam,10% in koothirkalam and mudhuvenil 37.5% cases were noted (Table 6) 
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Table 7a. 
Distributions of patients with kabasuram according to Vali (Vatham) 
Types of vatham No of Cases Percentage (%) 
Pranan 40 100 
Abanan 20 50 
Viyanan 40 100 
Uthanan 40 100 
Samanan 40 100 
Naagan 0 0 
Koormam 0 0 
Kirukaran 32 80 
Devathathan 40 100 
Dhananjeyan - - 
 
 
Inference: 
 According to vadham, derangement of Pranan,viyanan, Uthanan,  Samanan and 
devathathan were 100%, Abanan was deranged in 50%, kirukaran was deranged in 
80%(Table7a). 
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Table 7.b 
Distributions of patients kabasuram according to Azhal (Pitham) 
Types Of Azhal No. of Patients Percentage (%) 
Analagam (Aakanal)  40 100 
Ranjagam (Vannaerri) 13 32.5 
Sathagam (Aatralangi ) 40 100 
Alosagam (Nokkanal) - - 
Prasagam (Oollolithee) 13 32.5 
 
 
Inference:  
According to Pitham, derangement of Analagam, Satagam was deranged in 100%, 
Ranjagam, Prasagam was deranged in 32.5% (Table7b). 
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 - 74 - 
Table 7.c 
Distributions of patients with kabasuram according to Iyam (kabam) 
 
Types of  Iyyam No. of Patients Percentage (%) 
Avalambagam (Alliyyam) 40 100 
Klethagam (Neerpiyyam) 40 100 
Pothagam (Suvaikanaiyyam) - - 
Tharpagam (Niraivaiyyam) - - 
Santhigam (Oondriyyam) 40 100 
 
 
 
Inference:  
 According to Kabam, derangement of Avalambagam, kelathagam, santhigam 
were 100%. (Table7c). 
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Table  8. 
Distributions of patients with kabasuram according to Ezhu Udal Thaathukkal 
Udal thaathukkal No of Patients Percentage (%) 
Saaram   40 100 
Senneer  13 32.5 
Oon  0 0 
Kozhuppu 0 0 
Enbu    0 0 
Moolai      0 0 
Sukkilam 0 0 
Suronitham 0 0 
 
 
 
Inference:  
Saram was affected in 100% of cases, Senneer was affected in 32.5% of cases 
(Table8). 
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Table – 9 
Distributions of patients with kabasuram according to Envagai thervugal 
Ennvagai thervukal No of cases Percentage 
Naadi: Vathapitham                    
 Pithavatham
 Pithakabam 
30 
8 
2 
75 
20 
5 
Sparisam 40 100 
Naa 13 32.5 
Niram 13 32.5 
Mozhi - - 
Vizhi 13 32.5 
Malam 20 50 
Moothiram - - 
 
 
Inference: 
In Naadi, Vathapitham was observed in 75% of cases, Pithavatham was observed 
in 20% of cases, Pithakabam was observed in 5% of cases.   
Out of 40 cases coated and slightly dried tongues were noted in 32.5% cases.  
In Niram, pallor of skin was observed in 32.5% of cases. 32.5% of cases were 
found pallor conjunctiva. Out of 40 cases,  veppam was observed in all 100% of 
cases.Out of 40 cases, constipation was observed in 50 % of cases. (Table 9) 
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Table - 10 
Distributions of patients with kabasuram  according to Neikuri 
 
Neikuri No. of Patients Percentage (%) 
Vaatham 10 25 
Pitham 9 22.5 
Kabam 21 52.5 
 
 
 
Inference 
According to Neikuri, Vatha neer was observed in 25% of cases, pitha neer was 
observed in 22.5% of cases, Kaba neer was observed in 52.5% of cases (Table10). 
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Table - 11 
Distributions of patients with kabasuram according to the clinical features 
Clinical Features 
No of patients 
observed  Before 
treatment 
Percentage 
(%) 
No of patients 
observed after 
treatment 
Percentage 
(%) 
Fever 40 100 0 0 
Cough with 
expectorant 
40 100 12 30 
Running nose 30 75 10 25 
Headache 20 50 20           0 
Constipation 20 50 10 25 
Malaise 40 100 6 15 
 
 
Inference 
Among the 40 cases, 100% of the patients had fever, 75% had running nose, 50% 
of patients had head ache, 50% of patients had constipation and  100% of cases had 
malaise. At the end of the treatment, cough in 30% of cases, running nose  in 25% of 
cases, constipation in  25% of cases, malaise in 15% of cases, were noted. (Table11). 
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12. Laboratory investigations 
Most of cases were had increased WBC , reduced hemoglobin level. Sputum for AFB negative for all cases. 
S.NO OP/IP NO. NAME 
Age/ 
Sex 
(Haematology) BEFORE TREATMENT (Haematology) AFTER TREATMENT 
Total 
WBC 
Cells/ 
cu.mm 
DIFFERENTIAL 
COUNT 
ESR 
(mm) 
Hb 
Gm% 
TRBC 
cells 
/cu.mm 
Total 
WBC 
Cells/ 
cu.mm 
DIFFERENTIAL 
COUNT 
ESR 
(mm) 
Hb 
Gm% 
TRBC 
cells 
/cu.mm 
P L E M 1/2 hr 
1 
hr P L E M 
1/2 
hr 
1 
hr 
1 C53030 Durga sri 5/Fch 8100 41 56 3 - 4 8 10.2 3.9 7900 55 30 2 2 3 6 11 4 
2 C90187 Santhosh 5/Mch 9000 52 44 4 - 3 6 10.4 3.9 8400 56 40 3 1 2 4 10.4 4 
3 C25779 Dinesh 10/ Mch 13800 50 47 13 - 6 15 9.2 3.4 10500 52 46 2 - 4 8 10.2 3.4 
4 C91662 Asharaf Ahmed 
2.6./ 
Mch 10400 52 45 15 - 6 14 7 2 9500 56 40 3 1 4 8 10 3.2 
5 C85499 Jeno 3.6/ Mch 7900 54 40 10 - 4 8 7 3.9 7100 51 47 2 - 3 6 10 4 
6 C87674 Allees 7/ Fch 8800 52 44 8 - 3 6 11.1 3.6 8400 58 40 2 - 2 4 11.3 3.6 
7 C65120 yogesh 9/ Mch 8100 50 44 9 - 4 8 7.2 2.4 8000 55 44 1 - 2 4 10 3.3 
8 C91433 Mathu 3/ Mch 7200 54 39 4 2 4 8 7.6 2.8 7000 59 36 4 1 2 6 10.1 3.3 
9 B4713 Mano 6/ Mch 8200 57 40 2 - 2 4 8.4 2.5 7800 51 46 2 1 2 4 9 3.4 
10 C45335 Fasuruthin 6/ Mch 10100 70 27 2 - 2 4 9.6 2.5 9900 65 33 2 - 2 4 9.6 3 
11 C86892 Harini 9/ Mch 6000 55 41 4 2 4 8 9.3 3.1 5800 56 43 1 - 3 8 9.3 3 
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12 B16124  Priya 5/ Fch 8500 60 38 6 1 4 8 10 3.8 8200 55 44 1 - 2 4 10.2 3.8 
13 A56336  sachin 10/ Mch 8000 58 41 5 - 6 12 9 2.8 7900 55 44 1 - 4 8 9.6 3 
14 B90896  Pream 10/ Mch 7500 51 47 7 - 5 10 8.2 2.8 7100 50 47 1 2 3 8 8.2 2.7 
15 C62190  Ramesh 2/Mch 8100 60 34 9 1 6 14 11.5 4 7900 52 46 2 - 2 6 12.2 4.1 
16 C93360  Manoj 3/Mch 9200 42 49 5 1 2 4 10 4 9200 54 44 2 - 2 4 10 3.1 
17 C93545  Suresh 8.6/Mch 7200 55 38 4 1 2 4 8 2.8 6900 56 40 4 - 2 4 9.6 3.4 
18 C59647  Arul 4/Mch 7700 58 34 4 3 3 6 9.1 3.5 7500 58 40 2 - 2 4 10 3.9 
19 C86189  Mani 3/Mch 6600 51 44 7 2 4 8 7.6 2.9 6500 50 47 2 1 2 4 9.3 3.2 
20 C83548  Lokesh 3/Mch 7000 48 48 9 2 5 12 9.8 3.7 6900 50 49 1  - 3 6 10 3.7 
21 C91013 Abdul rasheed 3/Mch 8100 41 56 3 - 4 8 10.2 3.9 7900 55 30 2 2 3 6 11 4 
22 C93997 Praveen kumar 4/Mch 9000 52 44 4 - 3 6 10.4 3.9 8400 56 40 3 1 2 4 10.4 4 
23 C36738 Revitha 3.6/ Fch 13800 50 47 13 - 6 15 9.2 3.4 10500 52 46 2 - 4 8 10.2 3.4 
24 D592 Vidya 6/ Fch 10400 52 45 15 - 6 14 7 2 9500 56 40 3 1 4 8 10 3.2 
25 D1579 Haripriya 4/ Fch 7900 54 40 10 - 4 8 7 3.9 7100 51 47 2 - 3 6 10 4 
26 C19335 Ponharini 4/ Fch 8800 52 44 8 - 3 6 11.1 3.6 8400 58 40 2 - 2 4 11.3 3.6 
27 C19334 Ponhariharan 4/ Mch 8100 50 44 9 - 4 8 7.2 2.4 8000 55 44 1 - 2 4 10 3.3 
28 D455 Mahalakshmi 10/ Fch 7200 54 39 4 2 4 8 7.6 2.8 7000 59 36 4 1 2 6 10.1 3.3 
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29 B49120 Varsha 10/ Mch 8200 57 40 2 - 2 4 8.4 2.5 7800 51 46 2 1 2 4 9 3.4 
30 D5479 Daniel 4/ Mch 10100 70 27 2 - 2 4 9.6 2.5 9900 65 33 2 - 2 4 9.6 3 
31 C52025 Vani 6/ Fch 6000 55 41 4 2 4 8 9.3 3.1 5800 56 43 1 - 3 8 9.3 3 
32 D6735 Aruna 3/ Mch 8500 60 38 6 1 4 8 10 3.8 8200 55 44 1 - 2 4 10.2 3.8 
33 D4964 Yamini 10/ Fch 8000 58 41 5 - 6 12 9 2.8 7900 55 44 1 - 4 8 9.6 3 
34 C 80032 Bavishiya 2.6/ Fch 7500 51 47 7 - 5 10 8.2 2.8 7100 50 47 1 2 3 8 8.2 2.7 
35 D6256 Durgadevi 9Mch 8100 60 34 9 1 6 14 11.5 4 7900 52 46 2 - 2 6 12.2 4.1 
36 B21840 Sajeena 2/Fch 9200 42 49 5 1 2 4 10 4 9200 54 44 2 - 2 4 10 3.1 
37 484 Abitha 4.6/Fch 7200 55 38 4 1 2 4 8 2.8 6900 56 40 4 - 2 4 9.6 3.4 
38 1000 Dinesh 10/Mch 7700 58 34 4 3 3 6 9.1 3.5 7500 58 40 2 - 2 4 10 3.9 
39 1039 Durga Devi 9/Fch 6600 51 44 7 2 4 8 7.6 2.9 6500 50 47 2 1 2 4 9.3 3.2 
40 1029 Mohamed Sagin 5.6/Mch 7000 48 48 9 2 5 12 9.8 3.7 6900 50 49 1  - 3 6 10 3.7 
       L  - Lymphocyter, E – Eosinophi, M – Monocyte, P – Polymorphs, ESR – Erithrocyte Sedimentation Rate 
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LABORATORY INVESTIGATION 
S.NO 
OP NO./            
IP NO 
BEFORE TREATMENT AFTER TREATMENT 
WIDAL RA 
PERI SMEAR URINE 
WIDAL RA 
PERI SMEAR URINE 
MP MF BS BP URO MP MF BS BP URO 
1 C53030 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
2 C90187 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
3 C25779 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
4 C91662 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
5 C85499 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
6 C87674 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
7 C65120 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
8 C91433 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
9 B4713 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
10 C45335 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
11 C86892 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
12 B16124 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
13 A56336 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
14 B90896 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
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15 C62190 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
16 C93360 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
17 C93545 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
18 C59647 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
19 C86189 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
20 C83548 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
21 C91013 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
22 C93997 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
23 C36738 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
24 D592 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
25 D1579 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
26 C19335 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
27 C19334 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
28 D455 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
29 B49120 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
30 D5479 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
31 C52025 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
32 D6735 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
33 D4964 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
34 C 80032 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
35 D6256 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
 - 84 - 
36 B21840 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
37 484 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
38 1000 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
39 1039 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
40 1029 Negative Negative Nil Negative Nil Negative Not Presant Negative Negative Nil Negative Nil Negative Not Presant 
 
MP-Malarial parasite, MF-Malarial falciparum ,  RA-Rheumatoid arthritisfactor 
BS-Bile salt 
BP-Bile pigment 
Uro-Urobilinogen 
ESR-Erithrocytesedimentatinrate
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13. Biochemical analysis 
The Bio chemical analysis of trial medicine showed the presence of Chloride, 
Ferrous Iron, Starch, Tannin, Phosphate, Alkaloids, aminoacids, proteins,flavonoids 
Table - 14 
Result 
Result No. of Patients Percentage (%) 
Good 31 77.5 
Moderate 9 22.5 
Total 40 100 
 
 
Inference: 
Out of the 40 cases, the signs and symptoms were good in 77.5% of cases, 
moderate in 22.5% of case. These results were based on the clinical improvement. 
 
77%
23%
Results
Good Moderate
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6. DISCUSSION 
“Kabasuram” is a most common infectious disease of respiratory tract of 
childhood. Karasuram more or less resembles Acute Bronchitis in modern literature. The 
disease is characterized by fever, cough, with or without expectoration, constipation,  
malaise, rigor, polyarthralgia.  
In the present study, forty cases were treated in the outpatient and inpatient 
department, according to clinical features mentioned in textbook of Balavagadam.  
The diagnosis is based on clinical observation and laboratory investigations.  
The diagnosis were confirmed and treated with the drug “SilaethumaSura 
Kudineer” and clearly observed.  
This study evaluates the effect of ‘SilaethumaSura Kudineer ” in relieving the 
symptoms of Kabasuram.  
 
CLINICAL REVIEW 
· Age: 
 In the present study, maximum number of patients were in the age group of 2-4 
years (47.5%) and 7-10 years (30%).  
· Sex:  
Maximum number of patients (55%) was male.  
· Seasonal Variation:  
Rainy season was the triggering factor in aggravation of the disease kabasuram 
and was observed in 52.5% of patients in kar kalam. kabasuram is highly influenced by 
seasonal variations. 
· Vali (Vatham) 
Due to the derangement of different vatha the following symptoms occur. Pranan 
was affected in 100% cases and causes cough and wheezing. Abanan was affected in 50% 
and causes constipation. Samanan was affected in 100% cases and causes loss of appetite. 
Uthanan was affected in 100% of cases and causes cough, Kirukaran was affected in 80% 
and causes cough. And Devathathan was affected in affected in 100% cases and causes 
malaise. 
· Azhal (Pitham) 
Due to the derangement of Pitham the following symptoms occur. Analagam was 
affected 100% and causes poor appetite. Ranjakam was affected 32.5% and causes 
 - 87 - 
reduced haemoglobin. Saathakam was affected 100% and causes fatigue and malaise. 
Prasakam was affected 32.5% and causes pallor of skin. 
Iyyam (Kabam) 
 Deranged Avalambagam was affected 100% and causes cough. Klethagam was 
affected 100% and causes poor appetite.  
· Ezhu udarkattugal 
In Ezhu udal kattukal, Saram was affected 100% and causes malaise, fatigue., 
Seneer was affected 32.5% causes anaemia, anorexia and generalized weakness of the 
body. 
· Envagai thervugal 
 According to this study, 
Naa was affected in 32.5% of cases (coated, and pallor)  
Vizhi were affected in 32.5% of cases (pallor),  
Sparisam was affected in 100% 0f cases (raised temperature) 
Malam was affected in 50% of cases. 
· Naadi: 
 Vathapitham was observed in 75 % of cases,  
Pithavatham was observed in 20% of cases,  
Pithakabam was observed in5% of cases. 
According to naadi, high distribution observed in vali Azhal, Azhal vali and Azhal 
iyyam naadi.  
 
· Neerkuri 
Regarding moothiram, neerkuri showed straw coloured urine in all cases. 
· Neikuri 
In the present study, 25% of patient had vatha neikuri, 22.5% was observed as 
pitha neikuri and 52.5% was observed as kaba neikuri. According to this neikuri, kabam 
was dominately affected. 
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· Distribution according to clinical presentation 
of  the 40 patients of kanam in the present clinical trial,  
Fever in 100%  
Cough with expectoration 100%,  
headache in 50%,  
Malaise was seen in 100%. 
 The clinical improvements were accurately noted and further follow up was made 
in outpatient department. 
· Laboratory investigations 
Most of cases were had increased WBC and some cases were had reduced 
hemoglobin level. Sputum for AFB, Peripheral smear for MF, MP,RA factor, Widal  were 
negative for all cases. 
· Biochemical analysis 
The Bio chemical analysis of trial medicines showed the presence of aminoacids, 
proteins, flavanoids, ferrous iron, starch, tannin, phosphate, magnesium, sodium, 
alkalods. Ferrous iron is more soluble and therefore more readily absorbed. Iron helps in 
increasing the haemoglobin level of blood.  
· The pharmacological studies  
The siddha formulation SSK was tested for its reverse pharmacological and 
toxicological profiles in the experimental rats. The drug did not exhibit mortality at the 
dose of (2000ml/kg(V/W) equivalent to 2000 mg/kg/p.o(w/w), hence further test was not 
conducted with higher doses. According to OECD 423 guidelines, the substances did not 
exhibit mortality at the dose of 2000 mg/kg/p.o and above are “Unclassified” in the 
toxicity scale. 
The repeated oral toxicity study conducted for 14 days with the drug did not 
exhibit significant changes in Hb%,and other hematological parameters. Similarly the test 
drug  did not exhibit alteration in liver marker enzymes levels (AST , ALT,ALP)..  The 
drug did not  alter the body weight, food, water intake and behavioral parameters. The 
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drug did not exhibit any alteration in the function of kidney after repeated oral dosing for 
14 days. 
The test drug exhibited significant analgesic, antipyretic and anti-inflammatory 
activity in both acute and chronic experimental inflammatory conditions in rats. In cotton 
pellet granuloma the test drug (2.7ml/kg/p.o) exhibited significant (P<0.01) anti-
inflammatory activity which was comparable to that of Diclofenac Sodium (5 mg/kg/p.o). 
A similar result was also obtained with the test drug in carrageenan induced hind paw 
edema model. The test drug showed maximum anti-inflammatory activity at the end of 4th 
hour after carrageenan challenge. The result of test drug (2.7ml/kg/p.o) was comparable 
to that of Diclofenac Sodium ( 5 mg/kg/p.o). Since the maximum anti-inflammatory 
activity (reduction in the paw edema volume) was observed at the end of 4th hour, the 
mechanism of anti-inflammatory activity of test drug may be attributed for its inhibitory 
activity on cyclooxygenase (COX) enzymes. 
The pharmacological studies already reported on the individual drugs also favour 
its effect in disease Acute Bronchitis illness as given below 
 
Seenthil.parpadagam.koraikezhangu,chukku  have a effective anti inflammatory 
and Parpadagam. seenthil, chukku have a potent anti microbial, antipyretic activity and 
anti inflammatory activity. 
Seenthil  have effective immune modulator activity.  
Seenthil,parpadagam  have mainly antipyretic action and it reduces the 
temperature and vitalizes the deranged humour. 
The results of the study suggest that treatment with SILAETHUMA SURA 
KUDINEER has significant improvement in patients of KABASURAM. 
Out of the 40 cases, the signs and symptoms were good in 77.5% of cases, 
moderate in 22.5% of cases . These results were based on the clinical improvements. 
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7. SUMMARY 
Patients attending the OPD, IPD of NIS having the compliance of kabasuram 
diagnosed clinically and the patients were observed for clinical diagnosis, laboratory 
diagnosis. 
Classical symptoms of kabasuram with emphasis to symptoms of acute bronchitis  
like  Fever, Cough with or without expectorant, headache, constipation, poor 
appetite,myalgia 
Clinical diagnosis of kabasuram was done on the basis of clinical features 
described in Balavagadam text. 
Laboratory diagnosis was done by modern methods of examinations. 
Diagnosis had been based on the specially prepared proforma, including all 
clinical signs and symptoms of the disease, in which detailed history had been taken 
The signs, symptoms, and etiopathogenesis of lower respiratory illlness explained 
in modern diagnosis have lot of similarities with the disease entity kabasuram. 
The medicine chosen for clinical treatment and management of kabasuram is 
Silaethuma sura Kudineer internally two times in a day for 3days.   
All the patients were kept under strict dietary control during the treatment. The 
observation on effect of therapy was encouraging. 
The clinical efficacy of the drug was analyzed statistically on all the symptoms 
mentioned in the assessment criteria. The observation made during the clinical study 
showed that the trail drug Silaethuma sura Kudineer was clinically effective.  
In Bio chemical analysis, the trial medicine Silaethuma sura kudineer had ferrous 
iron, phosphate, Fluoride, starch, tannins, alkaloids, aminoacids, proteins, flavonids. 
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6. CONCLUSION 
All the forty patients of kabasuram were treated with Silaethuma sura Kudineer 
internally two (or) three times in a day. 
The ingredients of Silaethuma sura Kudineer are feasible and useful; these 
compounds may serve as potentially useful drug candidates for development at a lower 
cost. 
The medicine has many properties to control the signs and symptoms of 
kabasuram. During the course of treatment, no adverse interactions were observed. 
Clinical results were found to be significant good improvement was found in 
77.5% of cases, moderate in 22.5% of cases. 
Because of the efficient results clinically, the study may be carried over to further 
researches and it may motivate the upcoming generation to manage the disease 
kabasuram through the siddha medicine and also this study throw new glitters for the 
Siddha Medicine. 
The present clinical study has established that Silaethuma sura Kudineer is having 
good result in reducing the majority of symptoms of  kabasuram.  
Because of the encouraging clinical outcome the study may be further carried out 
with the same drug in a large Number of cases of Kabasuram. 
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STATISTICAL ANALYSIS 
All collected data were entered into computer using MS Excel software. The data 
entry was cross-checked manually with CRF. The data was analyzed using SPSS version 
18.0 software. The probability value 0.05 was taken as significant level. Paired‘t’ test was 
employed to determine the significance of blood sugar at before and after treatment.  
Mean ±Standard deviation of clinical features (CF) of kabasuram at - Before and 
after treatment  
CF –  Before treatment  5.56 ±1.095  t = 24.615, p <0.001  
 Significant 
CF –  After treatment  0.33 ±0.662 
 
The average clinical features of kabasuram at the start of treatment and after the 
treatment were 5.56 and 0.33 respectively.   
There is statistically significant difference between before and after treatment of 
clinical features of kabasuram(p<0.001). 
Mean ±Standard deviation of Hemoglobin (Hb) before and After treatment  
 Hb –  Before treatment  9.500 ± 1.62267 t = -3.139, p <0.0003  
Significant 
Hb - After treatment 10.045  ±1.1241 
The average Haemoglobin at the start of treatment and after the treatment was 
9.500 and 10.045 respectively. There is statistically significant difference between before 
and after treatment of Hemoglobin (p<0.0003). 
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9.ANNEXURE 
· Proforma 
· certificate 
· Bibliography 
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PROFORMA 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
A  STUDY ON KABASURAM [ACUTE BRONCHITIS]  IN CHILDREN 
Form I - PATIENT SCREENING FORM 
1.  S1. No:                               2. OP/IP No:   3. BED. No:  
 4.   NAME:                              5. AGE:   6. GENDER:  
7.  DATE:                        8.INFORMANT:  9.CONTACT. NO: 
10. DATE OF ENROLLMENT:                       11.DATEOF COMPLETION: 
 
a) INCLUSION CRITERIA 
Age: between 2-10 years 
Children who are having symptoms like 
Fever 
Difficulty in breathing 
Dry or productive cough 
Headache 
Constipation 
Running nose 
Malaise 
Polyarthralgia 
Willing to give blood specimen  for the investigation when required 
Willing to attend the OPD on 4th day 
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b) EXCLUSION CRITERIA: 
 A patient is not eligible for admission to the trial if any following is applicable. 
Convulsions 
Jaundice 
Typhoid 
Malaria 
Active primary complex 
Pneumonia 
Rheumatic fever 
Urinary tract infection 
Patient not willing to give biological sample when required. 
Patient  not willing to give consent for the study. 
 
 c) WITHDRAWL CRITERIA: 
       1.Exacerbation of symptoms. 
       2.Occurance of any side effect such as diarrhea,abdominal discomfort. 
       3.Patient turned to unwilling during the course of trial drug. 
        
    ADMITTED TO TRAIL :                     1.YES                     2.NO 
 
                If yes, S.No:                               1.IP                         2.OP 
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NATIONAL INSTITUTE  OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
A STUDY ON KABASURAM [ACUTE BRONCHITIS] IN CHILDREN 
Form: II CONSENT FORM  
 
CERTIFICATE BY INVESTIGATOR 
 
I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent. 
Signature………………….                                                                                                                                                                           
Date………………………                                                                                                          
Name…………………… 
 
CONSENT OF INFORMANT 
I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my Son/Daughter body functions. 
I am aware of my right to opt out of the trial at any time during the course of the trial 
without having to give the reasons for doing so. 
I exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of ‘SILETHUMA SURA KUDINEER’  for the treatment of 
‘KABASURAM’ [ACUTE BRONCHITIS]. 
                              
Signature………………… 
 
Date:        Name :…………………… 
 
Place:        Relationship:……………. 
 
 - 97 - 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A STUDY ON KABASURAM [ACUTE BRONCHITIS] IN CHILDREN 
FORM III –  CASE REPORT FORM 
 
1. S.No :                    2.OP/IP No:  3. Bed.No: 
 
4. Name  :     _______________________ 5. Age (Yr)  : 
 
6. Gender  : MC   FC 
 
7. Father’s Name         :  
 
8. Father’s Occupation  : 
  
9. Mother’s Name        : 
 
10. Religion : 
 
11. Monthly /Annual Income  :  
 
12. Socio Economical Level   : 
 
13. Informant     :    Mother     Father    Guardian          ---------------  
  
14. Postal Address : 
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15. Complaints and duration  :  
 
 
 
 
16. History of present illness  :  
 
 
 
 
17. Past History       :    
 
 
 
18. Family History :     1. Yes            2. No    
 
19.Personal Habits:         
           
           1.Picca  :                 1.Yes                                   2. No   
 
           2.Bed wetting:         1.Yes                                   2. No  
    
           3.Thumb sucking      1.Yes                                    2.No  
 
           4.Nail bitting           1.Yes                                   2.No 
 
 
20. Food Habits:    1. Veg           2. Non Veg                3.Mixed     
 
21. Immunization History  : Immunization whether given upon the national schedule 
                                         1.Yes                           2. No  
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GENERAL EXAMINATION: 
 
22.ANTHROPOMETRY 
 
1. Body weight (Kg) :    
 
2. Height (Cms) : 
 
3. Head circumference : 
    
4. Mid arm circumference : 
 
23.VITAL SIGNS: 
 
1. Body temperature ( F ) :  
 
2. Heart rate/minute : 
 
3.Pulse rate /minute  : 
 
4. Respiratory rate/minute :  
       
     1.Yes   2.No 
5. Pallor   : 
      
6. Jaundice   : 
 
7. Clubbing   : 
   
8. Cyanosis   : 
 
9. Pedal Oedema  : 
 
10. Lymphadenopathy : 
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24.EXAMINATION OF RESPIRATORY SYSTEM: 
a)     Inspection: 
Shape   : Normal            Barrel-Shaped        Pigeon chest 
Shoulder Drooping : Absent             Present 
Intercostals spaces : Normal             Bulge               Indrawing 
Spine                     : Normal             Kyphosis             Scoliosis 
Supraclavicular fossae: Normal            Flattening               Hollowing 
Position of mediastinum: 
 Traile’s sign:   Present              Absent 
 Apical impulse-------- 
· Palpation: 
Tenderness       Yes No 
             If yes___________ 
Tactile vocal Fremitus: Normal and equal 
Increased 
Decreased 
C)  Percussion:         
Percussion on all over area:      
Normal                     
Hyper resonance                                                            
Dullness 
D)   Auscultation: 
Intensity of breath sounds: Normal/decreased/increased __________ 
Adventitious sounds 
 Wheeze   Crepitations  Rub       None of above 
Vocal resonance: Normal/ Increased/ Decreased ______________ 
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25. EXAMINATION OF VITAL ORGANS 
 
1. CARDIOVASCULAR SYSTEM :  
 
2. ABDOMEN 
 
3.CENTRAL NERVOUS SYSTEM :  
 
26. CLINICAL ASSESSMENT: 
              1.Yes     2.No 
       
1. Fever  :   
 
2. Difficulty in breathing :                                
 
3.  Dry or productive cough:  
                                                      
 4. Headache  : 
 
 5.Running nose 
 
6.Constipation 
 
7. Malaise 
 
8.Polyarthralgia 
 
SPECIAL EXAMINATION: 
 
27.NILAM:  
 
· Kurinji   2. Mullai   3.Marutham 
 
· Neithel   5. Paalai     
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28. KAALAM:    
 
1. Kaarkalam    2.  Koothirkaalam 
 
3.  Munpanikaalam   4. Pinpanikaalam 
 
            5. Illavenirkaalam   6. Muthuvenirkaalam 
 
 
29. YAAKAI: 
 
1. Vatham   2. Vatha pitham  3.VathaKabam 
 
 4.   Pitham   5. Pitha vatham  6.PithaKabam 
 
 7.   Kabam   8. Kaba vatham  9.Kabapitham 
 
29. GUNAM:   
1. Sathuvam   2. Rasatham   3. Thamasam  
   
30.PORI PULANGAL: 
    1. Normal  2. Affected 
                                                                                        PORI     PULANGAL 
1.Mei                                                                                          _______    _______                                                                                      
2.Vaai                                                                               _______   _______   
3. Kan                                                                              _______   _______   
4. Mooku                                                                                    _______    _______  
5.Sevi                                                                                         _______    _______  
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31.KANMENDHIRIUM / KANMAVIDAYAM 
 
1. Normal    2. Affected  
   
 
 1. Kai                                                                               _______  _______ 
2. Kaal                               _______  _______ 
3. Vaai            _______  _______ 
4. Eruvai           _______  _______ 
5. Karuvai           ________ _______  
 
32.UYIR THATHUKKAL 
a)VATHAM :  1. Normal  2. Affected 
 
1. Pranan                ______________ 
   
2. Abanan                  ______________ 
   
3. Viyanan                _______________ 
 
4. Uthanan               _______________ 
 
5. Samanan               _______________ 
 
6. Nagan               _______________ 
 
7. Koorman               _______________ 
 
8. Kirukaran              _______________ 
 
9. Devathathan             _______________ 
 
10. Dhananjeyan             _______________  
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b)PITHAM   1. Normal  2. Affected  
 
1. Analam        _______________ 
 
2. Ranjagam        _______________ 
 
3. Saathagam        _______________ 
 
4. Alosagam        _______________ 
 
5. Prasagam        _______________ 
 
c)KABAM   1. Normal  2. Affected 
 
1. Avalambagam       _______________ 
 
2. Kilethagam                  ______________  
  
3. Pothagam        _______________ 
 
4. Tharpagam                  _______________ 
 
5. Santhigam        _______________ 
 
33.UDAL THATHUKKAL  1. Normal   2. Affected 
 
1. Saaram        _______________ 
 
2. Senneer        _______________ 
 
3. Oon                   ______________ 
 
4. Kozhuppu        _______________ 
 
 - 105 - 
5. Enbu        _______________ 
 
6. Moolai        _______________ 
 
7. Sukilam / Suronitham      _______________ 
 
34. ENVAGAI THERVUGAL 
    1. Normal  2. Affected 
 
1. Naa : 1.Colour       _______________ 
 
              2.Character                                                                ______________ 
 
              3.Sensory function                                                     ______________ 
 
 
2. Niram        _______________ 
 
3. Mozhi        _______________ 
 
4. Vizhi : 1.Co lour       _______________ 
 
               2.Character                                                               _______________ 
  
               3. Sensory function                                                  _______________ 
 
 5. Sparisam        _______________ 
 
6. Malam:    1. Normal   2. Affected 
 
          1.Niram                                      ____________ 
 
          2.  Nurai                                                                             ____________ 
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          3. Elagal/Erugal                               ____________ 
   
          4. Murai                   _____________ 
 
 
7. Moothiram:  Neer kuri 1. Normal      2. Affected 
 
        1. Niram        _______________ 
 
        2. Edai        _______________ 
 
       3. Manam        _______________ 
 
       4. Nurai        _______________ 
 
       5. Enjal        _______________ 
 
       6. Nei kuri:         
         1.Vatham  2.Pitham  3.Kabam    4.Thontham  
 
8. Naadi- 
 
1) Thani naadi: 
1. Vatham     
2. Pitham   
3. Kabam  
 
2) Thontha Naadi: 
1. Vatha pitham 
2. Pitha vatham 
3. Pitha kabam 
4. Kaba pitham 
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  3) Mukkutra Naadi: 
                            
 4)Thoda Naadi: 
                         1. Vatha kabam 
                         2. Kaba  vatham 
 
35. DRUGS ISSUED: 
Amount of drugs : 
1. No. of Packs  --------------------------------- 
8 grams/16grams: 
  
Date  : ___________________    
 
 
     Signature of Doctor 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
A STUDY ON KABASURAM [ACUTE BRONCHITIS] IN CHILDREN 
LABORATORY INVESTIGATIONS 
 
1. SI. NO:                                           2. OP/IP NO:                        3. BED. NO:  
 4.   NAME:                                           5. AGE:                                6. GENDER:  
 7.    DATE:                                           8.INFORMANT:                    9.CONTACT.NO: 
          10.  DATE OF ENROLMENT:                11. DATE OF COMPLETION: 
 
Date:      Lecturer                          HOD 
 
 
      TEMPERATURE 
Routine Blood Investigations Normal Values 
Before 
Treatment 
Date: 
After 
Treatment 
Date: 
Hb ( gms%)  11.5 – 14.5    
T.RBC (milli /cu.mm)  4-4.9   
 
ESR (mm) 
½ hr. 0- 4   
1 hr.  0-13   
T.WBC (milli /cu.mm) 5000-14500   
Differential Count (%) 
Polymorphs 40-75   
Lymphocytes 28-48   
Monocytes 3-6   
Eosinophils 0-3   
Basophils 0-1   
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Urine 
Investigation 
Before TMT 
Date: 
After TMT  
Date: 
Albumin   
Sugar   
Deposits   
Bile salt             
Bile pigment   
Urobilinogen   
 
SPECIFIC INVESTIGATION: 
1.Sputum for AFB 
2.X ray Chest 
3.Widal 
4.RA factor 
5.peripheral smear for MP,MF 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
A STUDY ON KABASURAM [ACUTE BRONCHITIS] IN CHILDREN 
1.  SI. No:    2.OP/IP  No:                      3. BED. No:  
 4.   NAME:                                      5. AGE:                                  6. GENDER: 
 7.  DATE :                8. INFORMANT  9. CONTACT NO 
 10. DATE OF ENROLLMENT  11.DATE OF COMPLETION 
           
S.NO 
CLINICAL FEATURES 
(SIGNS AND 
SYMPTOMS) 
BEFORE THE 
TREATMENT 
(0 th day) 
DURING THE 
TREATMENT 
(4 th day) 
AFTER THE 
TREATMENT 
(15th day) 
1. FEVER    
2. DRY OR PRODUCTIVE 
COUGH 
 
  
3. HEADACHE    
4. RUNNING NOSE    
5. CONSTIPATION    
6. 
MYALGIA  
  
7. 
POLYARTHRALGIA  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
A STUDY ON KABASURAM [ACUTE BRONCHITIS ] IN CHILDREN 
FORM V – CLINICAL ASSESSMENT PROFORMA 
WITHDRAWL FORM 
1.  OP/ IP No:    2. BED No:   3. Sl. No: 
 4.   NAME:    5. AGE:   6. GENDER: 
7.  DATE :    8. INFORMANT:  9. CONTACT NO: 
10. DATE OF ENROLLMENT : 11.DATE OF COMPLETION: 
 
FORM  - WITHDRAWAL  
 
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   :  Yes/ No  
Long absence at reporting   :  Yes/ No 
Irregular treatment     :  Yes/ No 
Shift of locality     :  Yes/ No 
Complication adverse reactions if any :  Yes/ No 
Exacerbation of symptoms   :  Yes/ No 
Pt not willing to continue   : Yes/No 
 
 
 
         Signature of Principal Investigator   Signature of Parents/Guardian 
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¾¸Åø ÀÊÅõ 
¸ÀÍÃõ §¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý (º¢§ÄòÐÁÍÃ ÌÊ¿£÷)  ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì 
¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É  ¾¸Åø  ÀÊÅõ. 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷ :   Dr. Í.Í¸ó¾¢ 
 
 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷            :  §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
                            ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ, ¦ºý¨É-47. 
       §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý ¸ÀÍÃõ 
±ýÛõ §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý.  
 ¸ÀÍÃõ ±ýÛõ º¢ò¾ ÁÕòÐÅò¾¢ø ¦º¡øÄôÀÎõ §¿¡Â¡ÉÐ þÕÁø, 
Àº¢Â¢ý¨Á, ¾¡¸õ, ¿£÷ÍÕ ÍÃõ, Ó¾Ä¢Â ÌÈ¢Ì½í¸û ¸¡½ôÀÎõ ¾ý¨ÁÔ¨¼ÂÐ. 
 þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, §¾¨ÅÂ¡É ¬öÅ¸ 
ÀÃ¢§º¡¾¨ÉìÌ ¾í¸ÇÐ ÌÆó¨¾¨Â ¯ðÀÎò¾×õ ¯û§Çý. 
      þÐ ºõÀó¾Á¡É ¾í¸ÇÐ ÌÆó¨¾Â¢ý «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ 
¨Åì¸ôÀÎõ ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. þ¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ ¦¾¡¨¸Ôõ 
ÅÆí¸ôÀ¼ Á¡ð¼¡Ð 
 þó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¾í¸ÇÐ ÌÆó¨¾Â¢ý ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ 
Àðºò¾¢ø §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. 
 þó¾ ¬Ã¡öîº¢ìÌ ¾í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ÌÆó¨¾¨Â ¯ðÀÎòÐõ 
Àðºò¾¢ø, ¯ûÁÕó¾¡¸ (º¢§ÄòÐÁÍÃ ÌÊ¿£÷)  )  ãýÚ §Å¨Ç  (750Á¢¸¢-1Á¢¸¢) 
¸¡¨Ä, Á¾¢Âõ 
 Á¡¨Ä) 7¿¡ð¸û «øÄÐ «¾üÌ §ÁÖõ  º¢Ä ¾¢Éí¸ÙìÌ ¯ð¦¸¡ûÇ §ÅñÎõ. 
 þó¾ ¬Ã¡öîº¢Â¢ø §¿¡Â¢ÉÃ¡¸ §º÷ó¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ  
þø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ ¾í¸ÇÐ ÌÆó¨¾¨Â Å¢Äì¸¢ì ¦¸¡ûÇÄ¡õ. 
      þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ  
«È¢Å¾üÌõ Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É Dr. Í.Í¸ó¾¢ (Àð¼ §ÁüÀÊôÀ¡Ç÷, 
ÌÆó¨¾ ÁÕòÐÅ À¢Ã¢×). ¨¸ô§Àº¢ ±ñ: 9884653825 ±ô§À¡Ðõ ¦¾¡¼÷Ò ¦¸¡ûÇÄ¡õ. 
§ÁÖõ þó¾ ¬Ã¡öîº¢ìÌ IEC (¿¢ÚÅÉ ¿£¾¢¦¿È¢ìÌØ) º¡ýÚ ¦ÀÈôÀðÎûÇÐ 
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þó¾ ÁÕóÐ º¢ÈôÀ¡¸ ¸ÀÍÃõ  §¿¡öì¸¡¸ «í¸£¸Ã¢ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø 
ÜÈôÀðÎûÇÐ. ²ü¸É§Å ¯À§Â¡¸ò¾¢ø ¯ûÇÐ §À¡ýÈ ÁÕóÐ  þÐÅ¨Ã 
§¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾ Å¢¾ Àì¸ Å¢¨Ç×¸¨Ç ²üÀÎò¾Å¢ø¨Ä. 
 §ÁÖõ ¯½× Ó¨ÈÂ¢ø Àò¾¢Âõ ¸¡ìÌÁ¡Ú «È¢×Úò¾ ÀÎ¸¢ÈÐ. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
 
A STUDY ON  KABASURAM 
FORM– DRUG COMPLIANCE   
1.  S.l. No:    2. OP/ IP No:                      3.Name:                                                   
4. Age:      5.Gender:   6.Date of Enrollment:  
7.  Date of completion: 8.Informant:    9.Reliablity:   
 
NAME OF THE DRUG   :   SILATHUMA SURA kUDINEER 
FORM OF THE DRUG   :   Powder 
ADMINISTRATION & ADJUVANT :   Oral ,honey 
DOSE & DURATION   :  15-30Ml Thrice Daily for 3 Days  
NO. OF DRUG PACKETS GIVEN : 
NO. OF DRUG PACKETS RETURNED:  
 
Day Date of  Drug Intake Morning Evening 
Day 1    
Day2    
Day 3    
   
Signature of Principal Investigator  
 Date 
  
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
 A STUDY ON ‘KABASURAM’ – ADVERSE REACTION  FORM 
 
1.  S.l. No:    2. OP/ IP No:                      3. Name:                                                   
4.  Age:   5. Gender:   6. Date of Enrollment: 
7.  Date of completion: 8. Informant:    9. Reliablity:   
 
Name     : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Registration No   : 
Date of trial commencement  : 
Date of withdrawal from trial  : 
Description of adverse reaction : 
 
Date:      Signature of Principal Investigator 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
 
POST GRADUATE DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
A STUDY ON ‘KABASURAM – DIET FORM  
 
1.  S.l. No:    2. OP/ IP No:                           3.Name:                                                   
4.  Age:   5.Gender:   6.Date of Enrollment:  
7.  Date of completion: 8.Informant:    9.Reliablity:   
 
¯½× Àò¾¢Â Ó¨È¸û 
· À¡Ä¢ø Á¢ÇÌòàû, Áïºû àû, ÀÉí¸ü¸ñÎ ¸ÄóÐ ÌÊì¸×õ. 
· ÐÇº¢î º¡È¢ø §¾ý ¸ÄóÐ ¦¸¡Îì¸×õ. 
· Ýô Å¨¸¸û ¦¸¡Îì¸×õ. 
· àÐ§Å¨Ç Ãºõ, Ð¨ÅÂø ¾Ã×õ. 
· ÌÇ¢÷îº¢Â¡É, þÉ¢ôÒ ¦À¡Õð¸¨Ç ¾Å¢÷ì¸×õ. 
· Ò¨¸, àº¢, ÀÉ¢¸¡üÈ¢ø ¿¼Á¡ÎÅ¨¾ ¾Å¢÷ì¸×õ. 
 
 
Date:            Signature of Principal Investigator 
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                §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
«§Â¡ò¾¢¾¡º ÀñÊ¾÷ ÁÕòÐÅÁ¨É, ¦ºý¨É-47. 
Àð¼ §ÁüÀÊôÒ ÁÕòÐÅòÐ¨È. 
 
ÀÊÅõ : II 
¸ÀÍÃõ 
§¿¡öìÌ (º¢§ÄòÐÁÍÃ ÌÊ¿£÷)  ) ÀÃ¢¸Ã¢ôÒò¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ 
¬ö×. 
 
´ôÒ¾ø ÀÊÅõ 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸Àð¼Ð 
¿¡ý þó¾ ÁÕòÐÅ ¬ö¨Å ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ 
§¿¡Â¡Ç¢Â¢ý ¦Àü§È¡ÕìÌ ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ 
«Ç¢ì¸¢§Èý. 
§¾¾¢:        ¨¸¦Â¡ôÀõ: 
þ¼õ:        ¦ÀÂ÷: 
 
 
§¿¡ÂÇ¢Â¢ý ¦Àü§È¡÷ ´ôÒ¾ø ÀÊÅõ 
 
 ±ýÉ¢¼õ þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨Èô ÀüÈ¢Ôõ, þó¾ ÁÕòÐÅò¨¾ ¦¾¡¼÷óÐ ±ÉÐ ÌÆó¨¾Â¢ý 
¯¼ø þÂì¸ò¨¾ì ¸ñ¸¡½¢ì¸×õ, «¾¨Éô À¡Ð¸¡ì¸ ÀÂýÀÎõ ÁÕòÐÅ 
¬ö×ìÜ¼ô ÀÃ¢§º¡¾¨É¸û ÀüÈ¢Ôõ ¾¢Õô¾¢ «Ç¢ìÌõ Å¨¸Â¢ø ¬ö× 
ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
 ¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø ±ô§À¡Ð 
§ÅñÎÁ¡É¡Öõ ±ý ÌÆó¨¾¨Â Å¢ÎÅ¢òÐì¦¸¡ûÙõ ¯Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢§Èý. 
¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ 
(º¢§ÄòÐÁÍÃ ÌÊ¿£÷)  )  ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬ö×ìÌ 
±ÉÐ ÌÆó¨¾¨Â ¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý 
§¾¾¢: 
 
þ¼õ: 
                             ¦Àü§È¡÷ ¦ÀÂ÷ ¨¸¦Â¡ôÀõ:  
 º¡ðº¢ì¸¡Ã÷ ¦ÀÂ÷: ¨¸¦Â¡ôÀõ 
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